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ABSTRACT 
 
Micro/Nano-Patterning of Supported Lipid Bilayers: Biophysical Studies and 
Membrane-Associated Species Separation. (May 2008) 
Jinjun Shi, B.S., Tsinghua University, China 
Chair of Advisory Committee: Dr. Paul S. Cremer 
 
Micro/nano-patterning of supported lipid bilayers (SLBs) has shown 
considerable potential for addressing fundamental biophysical questions about cell 
membrane behavior and the creation of a new generation of biosensors.  Herein are 
presented several novel lithographic methods for the size-controlled patterning of SLBs 
from the microscale to the nanoscale.  Using these methods, chemically distinct types of 
phospholipid bilayers and/or Escherichia Coli (E. Coli) membranes can be spatially 
addressed on a single microchip.  These arrays can, in turn, be employed in the studies of 
multivalent ligand-receptor interactions, enzyme kinetics, SLBs size limitation, and 
membrane-associated species separation. 
The investigations performed in the Laboratory for Biological Surface Science 
include the following projects.  Chapters II and III describe the creation of lab-on-a-chip 
based platforms by patterning SLBs in microfluidic devices, which were employed in 
high throughput binding assays for multivalent ligand-receptor interactions between 
cholera toxin B subunits (CTB) and ganglioside GM1.  The studies on the effect of 
ligand density for multivalent CTB-GM1 interactions revealed that the CTB-GM1 
 iv
binding weakened with increasing GM1 density.  Such a result can be explained by the 
clustering of GM1 on the supported phospholipid membranes, which in turn inhibits the 
binding of CTB.  Chapter IV characterizes the enzymatic activity of phosphatase 
tethered to SLBs in a microfluidic device.  Higher turnover rate and catalytic efficiency 
were observed at low enzyme surface densities, ascribing to the low steric crowding 
hindrance and high enzyme fluidity, as well as the resulting improvement of substrate 
accessibility and affinity of enzyme catalytic sites.  Chapter V presents sub-100 nm 
patterning of supported biomembranes by atomic force microscopy (AFM) based 
nanoshaving lithography.  Stable SLBs formed by this method have a lower size limit of 
~ 55 nm in width.  This size limit stems from a balance between a favorable bilayer 
adhesion energy and an unfavorable bilayer edge energy.  Finally, chapter VI 
demonstrates the electrophoretic separation of membrane-associated fluorophores in 
polymer-cushioned lipid bilayers.  This electrophoretic method was applied to the 
separation of membrane proteins in E. Coli ghost membranes.   
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CHAPTER I 
INTRODUCTION 
 
Objective 
Surface patterning in array formats has become a commonly used methodology 
in a variety of fields including biochemistry, biotechnology, chemistry, materials 
science, etc.1-4  Such array systems have been successfully employed in high throughput 
assays for drug design, gene sequencing, new material discovery, and chemical/bio-
sensing.5-8  Although supported lipid bilayers (SLBs) provide an excellent model system 
to mimic the properties of cellular membranes, lipid bilayer patterning on surfaces has 
not been well considered until late 1990s.9,10  Recently, micro/nano-patterned SLB 
arrays have shown great potential for addressing fundamental biophysical questions 
about cell membrane behavior and creating a new generation of biosensors.11-13  The 
research presented in this dissertation aims to develop novel lithographic techniques for 
patterning SLBs on planar surfaces and address some biophysical and bioanalytical 
questions including multivalent ligand-receptor interactions, enzyme kinetics, size 
limitations of SLBs, and membrane protein separation.  
Since the pioneering work of partitioning SLBs into lithographically patterned 
grids in 1997, a number of techniques have been developed for bilayer surface 
patterning, including microcontact printing, photolithography, etc.10,13,14  Among them, 
____________ 
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SLBs patterning inside microfluidic devices provided a powerful on-chip platform for 
studying ligand-receptor interactions and enzyme kinetics with high throughput and low 
sample consumption properties.15-17  Chapters II and IV extend such bilayer-coated 
microfluidics to the studies of multivalent CTB-GM1 interactions and phosphatase 
enzyme kinetics as a function of ligand and enzyme density. 
Although each of the achieved SLBs patterning techniques has its merits, two 
problems remain unsolved: (1) spatially addressing bilayer arrays inside individual 
microfluidic channels, and (2) size-controlled patterning of bilayers from the microscale 
to the sub-100 nm scale.  Chapters III and V seek to develop novel lithographic methods 
to achieve the specific goals.  By utilizing deep UV lithography, Chapter III 
demonstrates that the light exposed protein monolayer in microchannels can be removed 
and SLBs can be subsequently deposited over the exposed area.  In a sequential 
patterning procedure, SLB patches with different components are spatially addressed 
into individual microfluidic channels.  Such a bilayer array-coated microfluidic device is 
proven to be suitable for multiple multivalent ligand-receptor interactions measurement 
in one-shot experiments.  Chapter V presents a size-controlled patterning technique by 
using AFM-based nanoshaving lithography.  The method enables the study of inherent 
size limitations of SLBs. 
Besides its great potential in biophysical studies, lipid bilayer patterning has also 
been applied in bioanaltyical science.  For instance, the patterning of SLBs containing 
small molecules, peptides, and membrane proteins is of great importance in biosensor 
array design.11,18  The separation of membrane-bound dyes by SLB electrophoresis also 
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requires the patterning of one SLB adjacent to another.19  Chapter VI aims to pattern 
Escherichia Coli (E. Coli) membrane containing membrane proteins next to polymer-
supported lipid bilayer medium and separate the proteins by electrophoresis.  Membrane 
protein separation and purification are tough tasks since many of the proteins are water 
insoluble and easily lose their structure and function.20  Thus, typical protein separation 
methods such as two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) are 
not well suitable.19,20  The proposed strategy in Chapter VI may allow us to circumvent 
the drawbacks. 
 
Supported Lipid Bilayers 
Supported Lipid Bilayers (SLBs), first pioneered by McConnell and his co-
workers21,22 two decades ago,  retain many of the structural and dynamic properties of 
cellular membranes  (Figure 1.1).9  For instance, the lateral lipid mobility is preserved by 
a thin water layer (~ 1 nm) trapped between the membrane and the underlying solid 
surface, and thus allows for the reorganization of membrane components.23-25  SLBs also 
provide a natural environment for embedding membrane proteins, receptors, membrane 
fragments, etc.26  Therefore, SLBs have served as biomimetics for a variety of chemical 
and biological processes which occur in cellular membranes.9  Examples include lipid 
phase separation27, lipid rafts formation28, membrane fusion and fission29,30, enzymatic 
reactions17,31, ligand-receptor interactions16,32-34, cell adhesion and growth35,36, 
immunological synapse37, viral attack38, etc.  Besides, SLBs are of great importance in  
 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.  Supported Lipid Bilayers biomimicking cellular membranes.  The top image 
is a fluid mosaic model of cellular membranes and the bottom image is a schematic 
representation of supported lipid bilayers.  The top image was adapted from 
www.wikipedia.org. 
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chemical/biological sensing11, drug discovery12, membrane-associated compounds 
separation19,39, protein purification40,41, prevention of protein adsorption in capillary 
electrophoresis42,43, and fabrication of matrices for tissue engineering44.   
SLBs can be formed by two general methods (Figure 1.2).  In the first method, 
the lower leaflet of the bilayer is formed by the Langmuir–Blodgett technique.  The 
hydrophobic tails of the lipids from the air-water interface will orient themselves toward 
the air, while the polar headgroups toward the hydrophilic substrate.  The upper leaflet is 
formed by the Langmuir-Schaffer procedure, which involves horizontally dipping the 
substrate to create the second leaflet.22    The second method is called vesicle fusion.21,45  
In this technique, SLBs are formed through the fusion of small unilamellar vesicles 
(SUVs) to a planar solid substrate.  SUVs are prepared by either sonication or vesicle 
extrusion.46-48  Either way it is relatively straightforward to incorporate these SLBs with 
species including peptides, channel forming proteins, ligands, etc. 
To support fluid lipid bilayers, the solid substrate surface should be smooth and 
clean.9,13  These substrates can be broadly classified into four categories (Figure 1.3).  
(1) The commonly used materials known to support lipid bilayers include borosilicate 
glass, fused quartz, mica, oxidized Si, etc.10,22,49  These surfaces are hydrophilic and 
need no further modification.  (2) Some conducting substrates such as gold are not 
suitable for SLBs formation.  By modifying the conducting surfaces with self-assembled 
monolayers (SAM) of alkanethiols, one lipid monolayer can be deposited on the well-
defined hydrophobic surface (Figure 1.3b).50 This kind of system is called supported 
hybrid bilayer.51  If the SAMs are generated by ω-functionalized alkanethiols, it will 
 6
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.  Two general methods for SLBs formation: (a) Langmuir-Blodgett pulling 
for the bottom layer and Langmuir-Schaffer pushing for the top layer, (b) vesicle fusion. 
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Figure 1.3.  Four categories of supported lipid bilayers: (a) solid-supported lipid bilayer, 
(b) hybrid lipid bilayer, (c) polymer-cushioned lipid bilayer, and (d) tethered bilayer 
lipid membrane. 
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facilitate the formation of lipid bilayers.52  Although both of the above SLB models 
provide useful platforms for studying ligand-receptor interactions, cell adhesion, lipid 
raft formation, etc., they have one fundamental drawback.  When transmembrane 
proteins, especially those presenting large peripheral domains, are incorporated in these 
SLBs, the bilayer-substrate distance (~ 1 nm) does not provide a sufficient internal water 
reservoir to avoid the direct contact between proteins and the solid surface, thus causing 
the denaturation of proteins.13,26   
To overcome this drawback, two strategies are provided by modifying the 
underlying substrate with cushions or tethers.26  (3) Polymer-cushioned lipid bilayers 
separate the membranes from the solid substrate by adding one hydrophilic polymer 
layer between the bilayer and substrate (Figure 1.3c).  These polymer cushions, such as 
cellulose53-55, dextran56, and polyelectrolytes57-61, can reduce the frictional coupling 
between membrane-incorporated proteins and the solid support.  (4) The alternative SLB 
model is called tethered bilayer lipid membrane (tBLM).  This strategy uses lipopolymer 
tethers, which include one terminal group that binds to the substrate, another terminal 
group that inserts into the lipid bilayer, and a hydrophilic linker (e.g. polyethylene 
glycol, PEG) that defines the water/ionic reservoir (Figure 1.3d).62-66  The reservoir 
space, controlled by the linker length, decouples the bilayer from the surface and enables 
the functional reconstitution of transmembrane proteins.  Such tBLM can also be created 
by attaching biotinylated vesicles to the surface through biotin-streptavidin interaction 
followed by PEG-triggered fusion of vesicles to form a planar bilayer.67,68 
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Patterning of Supported Lipid Bilayers  
One key feature of SLBs is the lateral fluidity of lipid molecules, which 
distinguishes them from other surfaces and allows them to closely resemble cellular 
membranes.  However, the lipid mobility also means the membrane components are 
continually mixing.  Surface patterning of fluid lipid bilayers preserves many of their 
distinctive properties of cell surfaces while creating broad opportunities for the 
manipulation, control, and analysis of membranes, and the reaction environments.10,14,69  
Moreover, large SLB arrays presenting combinatorial libraries of small molecules, 
peptides, or proteins provide an extremely rapid and powerful means of data collection.13   
Surface patterning of lipid bilayers has been achieved by a variety of techniques 
that can fall into two broad categories: indirect and direct patterning.  Indirect methods 
first introduce pre-patterned barriers into the solid substrate to prevent lipid diffusion, 
and then assemble lipid bilayers into the corrals.  Barrier pre-patterning can be 
constructed by using photolithography, soft lithography, electron-beam lithography, 
scanning probe lithography, and microcontact printing, with a variety of barrier materials 
including plastic, metals, metal dioxides, semiconductors, proteins, photoresists, 
polymers, and polymerized lipid bilayers.10,14-18,70-77  Direct patterning methods include 
simple mechanical scratching70,71, poly-dimethylsilane (PDMS) stamping and blotting72-
74, hydrogel stamping75, polymer lift-off76, robotic pin printing77,78, deep ultraviolet 
(deep UV) lithography79,80, air bubble collapse81, and dip-pen nanolithography82.  Most 
of the techniques show the ability controlling the size of SLB patterns down to micron 
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scale.  Dip-pen nanolithography82 and nanoshaving lithography83 are till now the only 
methods that can achieve sub-100 nm patterning of SLBs. 
Among these patterning methods, some are capable of spatially addressing 
different bilayer chemistries in one array.  For example, Cremer and Yang18 first showed 
the use of pulled microcapillaries to deliver unique vesicle solutions to an array of 
hydrophilic patches patterned on a substrate with hydrophobic barriers.  Subsequently, 
other methods have been developed for the same purpose, including microcontact 
printing,73-75 laminar flow vesicle deposition,84 mechanical erasing and writing,70 robotic 
pin printing,78 scanning probe lithography,85 and dip-pen nanolithography.82   
 
Applications of Lipid Bilayer Arrays 
Since the emergence of lipid membrane patterning technique developed by 
Groves et al.10, micro/nano-patterning of SLBs has shown great potential in fundamental 
and applied bioanalytical and biophysical research.  Due to its capability of presenting 
different biologically functional species, SLB arrays play a pivotal role in the 
development of biosensors, proteomics, and drug discovery.11-13,69  For example, small 
SLB arrays containing different concentrations of DNP hapten and cholesterol have been 
made for antibody sensing.18,86  Submicron-sized SLBs inside Au nanoholes has been 
employed for label-free biorecognition in conjunction with localized surface plasmon 
resonance.87,88  It is also believed that the SLB arrays incorporated with membrane 
proteins could provide valuable information for biological warfare sensing and for the 
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discovery of new drugs.12,69  A recent application of SLBs patterning is membrane-
bound compounds separation by supported bilayer electrophoresis.19 
These patterned lipid bilayers can also be employed to address fundamental 
biophysical questions about cell membrane behaviors. Micro-patterned SLBs have been 
applied in the investigation of cell adhesion and growth, radial location of T-cell 
receptors in immunological synapses, and membrane compartmentalization during 
receptor-mediated signaling.35,37,89-91  By incorporating SLB arrays in microfluidic 
devices, it provides a high-throughput platform for studying multivalent ligand-receptor 
interactions and enzymatic reactions at lipid membrane interfaces, and phase transition 
of lipid membranes.15-17,31,34,92-96 
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CHAPTER II 
GM1 CLUSTERING INHIBITS CHOLERA TOXIN BINDING IN SUPPORTING 
PHOSPHOLIPID MEMBRANES 
 
Introduction 
Multivalent ligand-receptor interactions are frequently utilized by nature because 
their properties can be remarkably different from the corresponding monovalent 
recognition events.  For example, multivalent interactions can achieve tighter binding, 
enhance receptor selectivity, induce receptor clustering on cell surfaces, and control 
signal transduction within cells.97  A great diversity of biological processes including 
cell signaling98 and cell-pathogen interactions99-101 are associated with multivalent 
ligand-receptor binding.  The recognition of cholera toxin (CT) by ganglioside GM1 is 
considered to be a paradigm of multivalent carbohydrate-protein binding.102  
Understanding the underlying physical chemistry of this model system should therefore 
lead to a better appreciation of multivalent binding phenomena and may provide insight 
into strategies for inhibitory drug design.97,99,103,104  
Cholera toxin is a member of the AB5 class of cytotoxins, composed of a 
catalytically active A subunit and doughnut-shaped homopentameric B subunits that 
recognize and bind to the pentasaccharide moiety of GM1 in the cell’s membrane.  The 
interaction of cholera toxin or its pentameric B-subunits with GM1 has been investigated 
*Reproduced with permission from “GM1 Clustering Inhibits Cholera Toxin Binding in Supported
Phospholipid Membranes” by Shi, J. J.; Yang, T. L.; Kataoka, S.; Zhang, Y. J.; Diaz, A. J.; Cremer, P. S.
J. Am. Chem. Soc. 2007, 129, 5954-5961.  Copyright 2007 American Chemical Society. 
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by using a variety of techniques.  125I-labeled CT was first utilized to study binding on 
isolated fat cells and liver membranes,105,106 and intestinal cells107.  Thermodynamic data 
were obtained by isothermal titration calorimetry.108,109  Surface plasmon resonance was 
used to obtain the kinetics of CTB binding to GM1 in supported bilayers110,111 and in 
vesicles112,113.  Other diagnostic methods used to explore CTB-GM1 binding include 
quartz crystal microbalance analysis,114 flow cytometry,115 fluoroimmunoassays,116 
fluorescence resonance energy transfer,117 atomic force microscopy,118 and a novel 
colloid phase transition method.33,119  The buffer conditions, temperatures, ionic 
strengths, and membrane chemistries varied amongst the different experiments.  
Accordingly, the measured values for the apparent dissociation constant, KDapp, ranged 
from 4.55 pM111 on the low end to 41 nM33 and even 370 nM94 on the high end.  
In multivalent binding systems ligand density is a key parameter, since it affects 
ligand distribution and interligand distance.97,99,104,120,121  We previously showed that 
KDapp for an antibody-antigen binding system tightened by a factor of ~ 12 as the ligand 
density increased from 0.1% to 5.0 mol% in a supported phospholipid membrane.16  The 
hapten was a dinitrophenyl (DNP) moiety covalently conjugated to the headgroup of a 
phospholipid, which was recognized by an anti-DNP IgG.  The change in KDapp with 
ligand density could be predicted extremely well by taking into account the dissociation 
constants for the individual steps in a sequential binding model: 
sD
DD
Dapp LK
KKK
][22
21
+=       (1) 
where KD1 and KD2 are the equilibrium dissociation constants for the first and second 
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binding events, respectively, and [L]s is the surface density of the ligands in the lipid 
bilayer.   
Beyond bivalent binding, very little work has been done to probe the effect of 
membrane ligand density for the binding of proteins with multiple binding pockets.  
Indeed, the thermodynamics and kinetics of CTB-GM1 binding have typically been 
studied at only one or a few ligand densities at a time.  Curiously, MacKenzie et al.112 
showed data that indicated approximately 4 times tighter apparent binding of CTB to 
liposomes containing 2.0 mol% GM1 than those containing 4.0 mol% GM1.  Lencer et 
al.122 investigated cholera toxin binding to an intestinal microvillus membrane during 
development that possessed different GM1 ligand densities.  In that case, the binding also 
appeared to be stronger at lower ligand density.  These results led us to hypothesize that 
a systematic study of multivalent CTB-GM1 binding over a range of GM1 concentrations 
could reveal that a different binding mechanism was at work than in the simple case of 
the bivalent ligand-receptor interaction of the DNP/anti-DNP system.   
In Chapter II, a series of binding experiments were performed within 
microfluidic channels coated with 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) bilayers containing GM1.  The results showed that the binding of CTB was 
continuously weakened as the ligand density was increased.  Atomic force microscopy 
(AFM) studies revealed GM1 clustering on the phospholipid membranes, which became 
more pronounced at increased GM1 densities.  Based on these observations, it is 
suggested that CTB binding to GM1 is inhibited by the clustering of the glycolipid 
within the phospholipid membrane (Figure 2.1).   
 15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Schematic representation of the inhibition of CTB binding by GM1 
clustering on supported POPC bilayers.  For simplicity GM1 molecules in the lower 
leaflet are not drawn. 
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Experimental 
Materials Ganglioside GM1 (Brain, Ovine-Ammonium Salt) and POPC 
were obtained from Avanti Polar Lipids (Alabaster, AL).  Texas Red-DHPE and Rabbit 
IgG antibodies were purchased from Molecular Probes, Inc. (Eugene, OR).  CTB from 
Vibrio cholerae was purchased from Sigma-Aldrich.  The CTB was labeled with Alexa 
Fluor-594 dye by using a standard protein-labeling kit (A10239, Molecular Probes, 
Eugene, OR).  Labeling yielded ~ 0.8 fluorophores per protein as determined by UV/Vis 
absorption spectroscopy.  The dye-labeled protein was stored in a phosphate buffered 
saline (PBS) solution containing 10 mM sodium phosphate, 150 mM NaCl, and 0.2 mM 
sodium azide.  The pH of the PBS was set to 7.2 by dropwise addition of 2.0 M NaOH.  
The same buffer was also used for vesicle preparation and the successive dilution of 
protein solutions.  Purified water for these experiments came from a NANOpure 
Ultrapure Water System (18.2 MΩ·cm, Barnstead, Dubuque, IA). 
 
Microfluidic Devices Fabrication We employed microfluidic devices and 
total internal reflection fluorescence microscopy to study CTB-GM1 interactions using 
our previously established methods.15,16  The devices were made from planar borosilicate 
glass substrates and lithographically patterned polydimethylsiloxane (PDMS) molds.  
The devices afforded high throughput capabilities and had extremely low sample 
consumption compared with traditional analytical tools.  Additionally, the glass and 
PDMS surfaces served as good supports for fluid phospholipid bilayers.9  Lipid mobility 
was preserved because a thin water layer (~ 1 nm thick)25 was trapped between the 
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phospholipid bilayer and the underlying solid surface.  Lipid molecules in the membrane 
were thus able to diffuse laterally to accommodate multivalent interactions. 
The seven-channel microfluidic devices used in these experiments were 
fabricated by soft lithographic techniques.15,123  In a first step, microfluidic channels 
were designed with Corel Draw software (Version 9, Corel Corp.).  By printing out the 
design and transferring it onto black and white high-contrast Kodak technical pan film, 
the image could be used as a photomask for photolithography.  Soda-lime glass slides 
were cleaned in hot surfactant solution (ICN x7 detergent, Costa Mesa, CA) for 1 h, 
rinsed with copious amounts of purified water, and dried with nitrogen gas.  Next, the 
glass slides were coated with a thin layer of hexamethyldisilazane (HMDS) to improve 
adhesion of the photoresist to the glass surface,124 followed by spin coating with Shipley 
1827 photoresist.  The substrates were then exposed to UV light through the photomask 
and treated with developing solution.  After baking the photoresist/glass systems at 120 
°C overnight, the substrates were immersed in buffered oxide etchant (BOE) in an 
ultrasonic bath to etch the glass.  After etching, the remaining photoresist was removed 
with ethanol.  PDMS was then poured over the glass masters and cured.  The elastomeric 
molds were carefully peeled off, washed with ethanol and purified water, and dried 
under a stream of nitrogen.  In the penultimate step, the molds were treated in an oxygen 
plasma for 30 s along with clean planar borosilicate glass substrates. It should be noted 
that the borosilicate substrates were cleaned in a boiling 1:3 solution of ICN x7 detergent 
and purified water.  Then the substrates were rinsed with copious amounts of purified 
water, dried with nitrogen, and annealed in a kiln at 480 °C for 5 hours before 
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introduction into the oxygen plasma.  Finally, the PDMS molds and glass substrates 
were brought into contact immediately after oxygen plasma treatment to create finished 
microfluidic devices. 
 
Preparation of Small Unilamellar Vesicles and Bilayer Formation Small 
unilamellar vesicles (SUVs) were prepared by vesicle extrusion.15,47,48  Lipids dissolved 
in chloroform were dried under a stream of nitrogen followed by overnight vacuum 
desiccation.  Next, the lipids were rehydrated in PBS buffer (pH 7.2).  After five freeze-
thaw cycles, the vesicles were extruded more than seven times through a polycarbonate 
filter (Whatman) containing 50 nm pores.  SUVs prepared by this method were 70 ± 10 
nm in diameter as determined by dynamic light scattering with a Brookhaven 
Instruments 90Plus Particle Size Analyzer. 
For bilayer formation, 5 µL of a 2.5 mg/mL SUV solution were injected through 
each inlet port of the linear array microfluidic device.  The solution was introduced 
immediately after plasma treatment and bonding of the PDMS/glass microfluidic 
platform to insure that the surfaces remained hydrophilic.  Vesicle fusion occurred on 
both the PDMS walls and the glass substrate to form a continuous lipid bilayer coating 
as has been previously reported.17  The incubation time for bilayer formation was 1 h.  
The microchannels were rinsed with PBS buffer to remove excess vesicles.  
Fluorescence recovery after photobleaching (FRAP)125,126 was employed to verify the 
quality of the supported bilayers on the glass surfaces from which all binding data were 
obtained. 
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All solid-supported membranes were made from the fusion of POPC vesicles 
containing a series of GM1 concentrations from 0 to 10.0 mol%.  The distribution of 
GM1 between the upper and lower leaflets of the supported bilayers was tested and 
found to be the same within experimental error using methods developed by Parikh and 
coworkers.127  Before the injection of protein solution, the bilayer-coated microchannels 
were incubated with a 0.5 mg/mL Rabbit IgG antibody solution for 30 minutes to block 
defect sites in the membrane and thereby suppress non-specific adsorption of CTB. 
 
Epifluorescence Microscopy and TIRFM To check the quality and fluidity of 
supported GM1/POPC bilayers, FRAP studies were conducted using an inverted 
epifluorescence Nikon Eclipse TE2000-U microscope with a 10× objective.  Laser 
radiation from a 2.5 W mixed gas Ar+/K+ laser (Stabilite 2018, Spectra Physics) was 
used to bleach the lipid bilayer samples.  FRAP images were obtained with a MicroMax 
1024b CCD camera (Princeton Instruments).  Total internal reflection fluorescence 
microscopy (TIRFM),128,129 which can discriminate between dye-labeled CTB molecules 
bound to the supported membrane and those in the bulk solution, was employed for the 
determination of binding isotherms.  In this case the fluorescence images were obtained 
with a Nikon E800 fluorescence microscope using a 4× objective.  In the TIRFM 
experiments, a 594 nm Helium-Neon laser beam (4 mW, Uniphase, Manteca, CA) was 
passed through a dove prism that was optically coupled to the bottom of the borosilicate 
substrate of the microfluidic device by index matching immersion oil.  Alexa 594-
labeled CTB solutions were simultaneously flowed through each channel at various 
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concentrations at a rate of 0.2 µL/min by a Harvard PHD 2000 syringe pump (Harvard 
Apparatus, Holliston, MA).  The Helium-Neon laser beam was telescoped out by a line 
generator lens (BK7 for 30°, Edmund Optics, Barrington, NJ) to create a uniform 
intensity profile across the microchannel array.  As the laser illuminated the interface 
between the bilayer-coated glass substrate and the bulk aqueous solution, it was totally 
internally reflected, creating an evanescent wave above the interface.  The evanescent 
wave decayed exponentially to its 1/e value by ~ 70 nm above the interface under the 
experiment conditions employed here.15,130  This allowed the proteins bound to the 
supported lipid bilayer to be studied with high specificity.  The TIRFM images were 
captured with a Micromax 1024b CCD camera, collected using Metamorph software 
(Universal Imaging Corp.), and transferred to Sigma Plot for further processing. 
 
Atomic Force Microscopy AFM images of supported lipid bilayers were 
acquired with a Nanoscope IIIa Multimode SPM (Digital Instruments, Santa Barbara, 
CA) equipped with a J-type scanner.  POPC bilayers samples were probed with 0.0 
mol%, 0.1 mol%, 0.5 mol%, 1.0 mol%, 3.0 mol%, 5.0 mol%, and 10.0 mol% GM1.  The 
experimental conditions were identical to those used in the microfluidic devices except 
for the fact that the PDMS mold above the glass surface was absent.  Instead, the bilayer 
coated borosilicate glass served as the bottom of a standard AFM liquid sample cell.  All 
images were obtained in fluid contact mode at a scan rate of 2.0 Hz using oxide-
sharpened DNP-S1 silicon nitride probes (spring constant: 0.06 N/m; Veeco Probes, 
Santa Barbara, CA).  The only treatment applied to the images was flattening.  GM1 
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domains were judged to be present on the POPC bilayer surface when the feature height 
exceeded 1.0 nm above the membrane background.  In this case, the nominal width of a 
domain was taken from the point where the feature height first began to rise above the 
background level and ended when it returned to background level.  To abstract more 
quantitative information on the GM1 cluster size, a standard deconvolution method was 
employed.131,132  For this purpose a nominal AFM tip radius of 10 nm was assumed 
(according to the manufacturer’s specifications) and a headgroup height of 1.0 nm for 
the GM1 features was also employed.  Under these conditions, the size of the GM1 
clusters, which had nominal mean diameters between 16.1 and 28.3 nm, were reduced by 
8.8 nm to take tip-sample convolution effects into account. 
 
Results 
A schematic representation of the lipid coated PDMS microchannels bonded to a 
planar glass support is shown in Figure 2.2a.  GM1/POPC bilayers were coated over the 
entire surface (shown in green).  The surface binding process was monitored by TIRFM 
as a function of time until the fluorescence intensity remained constant.  A typical TIRF 
image is shown in Figure 2.2b.  In this case the bulk CTB concentration ranged from 6.0 
nM to 0.090 nM (left to right).  Control experiments were conducted under the same 
conditions without GM1 in the POPC membrane.  Under these conditions, virtually no 
background fluorescence signal was observed, as the bulk protein concentrations were so 
low.115,118  Intensity profiles across the TIRF image (dotted red line in Figure 2.2b) were 
employed to obtain quantitative binding data. 
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Figure 2.2. (a) Schematic representation of bilayer-coated PDMS/glass microchannels. 
(b) TIRF image of a bilayer-coated microchannel array containing various 
concentrations of dye-labeled CTB. 
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In a first set of experiments, solid supported POPC bilayers containing 0.05, 0.5, 
and 5.0 mol% GM1 were prepared in separate parallel arrays of microfluidic channels 
and tested for CTB binding (Figure 2.3).  In order to abstract equilibrium dissociation 
constants, the CTB-GM1 binding curves were fit to both the Langmuir isotherm (eqn. 2) 
and Hill-Waud (eqn. 3) binding models:122  
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where F is the fluorescence intensity from surface bound proteins, Fmax is the maximum 
fluorescence intensity when proteins completely saturate the bilayer surface, [P] is the 
bulk CTB concentration, Kd and KH are the apparent equilibrium dissociation constants 
for the respective models, and n is the Hill coefficient of cooperativity.122  The Langmuir 
isotherm model32,133 is valid for pentavalent CTB binding to multiple ligands on the 
surface so long as the individual binding events are independent.112,114,119  On the other 
hand, the Hill-Waud model takes into account binding cooperativity by introducing the 
Hill coefficient, n.94,122  The Langmuir isotherm fit became progressively poorer as the 
concentration of surface bound ligands was increased.  In fact, the Hill-Waud model 
(regression coefficient, R2 = 0.99) more closely fit the CTB binding data in comparison 
to the Langmuir adsorption isotherm (R2 = 0.96) at the highest glycolipid concentration.  
The apparent dissociation constants Kd (0.69 ± 0.11 nM) and KH (0.50 ± 0.07 nM) were 
also somewhat different under these circumstances. 
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Figure 2.3. TIRF intensity of surface-bound CTB vs. bulk protein concentration at three 
different GM1 densities in POPC bilayers: (a) 0.05 mol%, (b) 0.5 mol%, and (c) 5.0 
mol%.  The dashed curves were fits to a Langmuir adsorption isotherm while the solid 
curves were fits to the Hill-Waud model. 
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Table 2.1.  CTB-GM1 binding constant as a function of ligand density. 
Conc. of GM1 (mol%) in 
POPC Bilayers 
Kd (nM) KH (nM) n 
0.02 0.11 ± 0.07 0.11 ± 0.05 1.3 
0.05 0.16 ± 0.05 0.15 ± 0.03 1.6 
0.1 0.23 ± 0.10 0.17 ± 0.06 1.5 
0.5 0.32 ± 0.07 0.26 ± 0.04 1.8 
1.0 0.39 ± 0.08 0.31 ± 0.05 1.9 
2.0 0.46 ± 0.15 0.37 ± 0.10 1.9 
5.0 0.69 ± 0.11 0.50 ± 0.07 2.0 
10.0 0.86 ± 0.09 0.59 ± 0.05 2.0 
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Similar experiments to those shown in Figure 2.3 were performed at eight GM1 
concentrations ranging from 0.02 to 10.0 mol% in POPC bilayers.  The fits to the Hill-
Waud and Langmuir binding models are provided in Table 2.1.  As can be seen, as the 
GM1 density was increased, the Hill coefficient, n, deviated ever further from 1.0 and KH 
became significantly different from Kd.  At the lowest GM1 density, however, Kd and KH 
were indistinguishable within experimental error and the Hill coefficient approached 1.0.  
This suggests that CTB binds cooperatively to GM1 at high ligand densities.  Such a 
finding is in agreement with previous observations.94,108,109,122  More significantly, the 
apparent equilibrium dissociation constant continuously weakened with increasing 
ligand density. 
The KH values as a function of GM1 concentration in the POPC bilayer from 
Table 2.1 are plotted in Figure 2.4.  As can be seen, the data do not show a linear trend 
as a function of ligand density.  Rather, the apparent dissociation constant weakens more 
sharply as a function of concentration at low GM1 concentrations, but begins to level out 
at higher concentrations.  The curve shape is reminiscent of a binding isotherm.  Two 
possible origins for this phenomenon need to be considered.  First, one might 
hypothesize that the weakening of the binding could be caused by clustering of the GM1 
lipids.  Alternatively, weakening of KH might be the result of electrostatic repulsion 
between the negatively charged CTB and the increasingly negatively charged membrane 
as the ligand density is increased (note: each GM1 headgroup has a charge of -1).111 
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Figure 2.4. KH vs. the concentration of GM1 in the POPC bilayers for CTB-GM1 
binding. 
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Figure 2.5. AFM images of GM1 clustering on POPC bilayers: (a) a pure POPC bilayer, 
(b) a POPC bilayer containing 0.5 mol% GM1, and (c) a POPC bilayer containing 5.0 
mol% GM1.  Each image is 500 nm × 500 nm. 
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To investigate GM1 clustering, AFM experiments were performed as a function 
of GM1 concentration in supported POPC bilayers in the absence of CTB.  A pure POPC  
membrane was imaged first as a control (Figure 2.5a).  As expected, the membrane 
looked relatively flat and featureless.  By contrast, systems containing 0.5 mol% GM1 
(Figure 2.5b) and 5.0 mol% GM1 (Figure 2.5c) contained 1.0 ~ 2.0 nm high features 
which are consistent with the presence of GM1.134  In fact, the height of the GM1 
pentasacchride headgroup has been measured by X-ray diffraction and is consistent with 
this finding.135,136  POPC bilayers containing 0.1 mol%, 1.0 mol%, 3.0 mol%, and 10.0 
mol% GM1 were also imaged by AFM.  The apparent size of the domains in these 
images ranged from approximately 15 to 60 nm.  Consistent with expectations, these 
domains were more prevalent at high GM1 density (e.g. 5.0 mol%) than at low density 
(e.g. 0.5 mol%). 
To quantify the domain size distribution in the POPC bilayers, the approximate 
diameter of the GM1 domains were measured and counted from four independent 500 
nm × 500 nm AFM micrographs at each ligand density.  Histograms for the number of 
GM1 domains as a function of apparent cluster size at GM1 densities between 0.1 mol% 
and 10.0 mol% are provided in Figure 2.6.  As can be seen from Figures 2.5 and 2.6, 
GM1 clustering within the POPC bilayers became more pronounced at increased GM1 
densities.  The mean domain size after deconvolution at 0.5 mol% was 11.0 nm and this 
value rose to 18.6 nm for 5.0 mol% GM1.  In fact, the mean domain size continually  
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Figure 2.6. Histograms for the distribution of GM1 domains within POPC bilayers: (a) 
0.1 mol%, (b) 0.5 mol%, (c) 1.0 mol%, (d) 3.0 mol%, (e) 5.0 mol%, and (f) 10.0 mol% 
GM1/POPC. 
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Table 2.2. GM1 domain size as a function of ligand density. 
GM1 mol% 
Calc. GM1 surface 
conc. (nmol/dm2) 
Apparent mean 
size (nm) 
Mean size after 
deconvolution (nm) 
10.0 2.37 28.3 19.5 
5.0 1.19 27.4 18.6 
3.0 0.71 24.1 15.3 
1.0 0.24 22.4 13.6 
0.5 0.12 19.8 11.0 
0.1 0.024 16.1 7.3 
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shifted from ~ 7 nm to ~ 20 nm as the GM1 density was increased from 0.1 mol% to 10.0 
mol% (Table 2.2). 
To further elucidate the binding mechanism as a function of ligand density, the 
shape of the KH vs. GM1 ligand density curve shown in Figure 2.4 needs to be 
considered.  As mentioned above, the curve shape is reminiscent of a binding isotherm.  
Treating the curve in this manner requires that the y-axis be considered in a fashion 
analogous to a fractional coverage of available sites.  This was achieved by fitting the 
data in Figure 2.4 to a binding isotherm equation, y = y0 + ymaxx/(b+x), to obtain the y 
intercept (y0 at x = 0) and the maximum value (ymax at x = ∞).  By offsetting y0 to 0 and 
normalizing ymax to equal 1, the y-axis essentially becomes analogous to a surface 
coverage.  On the other hand, the x-axis must be treated as a two dimensional 
concentration.  This can be done by noting that 1.0 mol% GM1 is equivalent to a number 
density of 0.237 nmol/dm2 (assuming an average area per POPC lipid of ~ 0.7 nm2).137  
Number density units of square decimeters rather than square meters are employed in 
analogy to molar units which are moles/dm3.  Doing this produces an equation in the 
form: 
ss
s
LB
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+=      (4) 
where f is a unitless fraction which ranges from 0 to 1.  [L]s is the two-dimensional 
number density of the glycolipid.  The subscript, s, is used to denote the fact that this is a 
surface concentration.  Bs is the apparent two-dimensional dissociation constant which  
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Figure 2.7. Fitted plots of (a) f and (b) the square of characteristic domain size, (Φ2), vs. 
the GM1 surface concentration in POPC membranes. 
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also has units of moles/dm2.  The value of f approaches zero if all of the glycolipids are 
separated from one another and reaches 1.0 when they are completely clustered.  A fit to 
the data is shown in Figure 2.7a.  The abstracted parameter, Bs = 0.50 nmol/dm2, is a 
remarkably good fit to the data (R2 = 0.99).  This would imply that half of the 
ganglioside molecules are clustered at 2.1 mol% GM1 in the POPC membrane. 
The abstracted value of Bs for GM1 clustering should be compared with the AFM 
data in Table 2.2.  To do this, the square of the mean domain diameter, Φ2, is plotted as a 
function of GM1 density in Figure 2.7b.  Φ2 was chosen instead of Φ because it is 
proportional to the area of the GM1 domains and, hence, to the number of glycolipids.  
By fitting the domain area data to a Langmuir isotherm, a nominal equilibrium 
dissociation constant for GM1 clustering on the POPC bilayer can nominally be 
extracted.  The result gives an apparent value of Kd = ~ 1.4 mol% GM1 for the AFM 
data, which is a rather close match to the results in Figure 2.7a.  This is strong evidence 
that GM1 clustering is correlated to the observed weakening of the equilibrium 
dissociation constant for CTB-GM1 as a function of glycolipid density. 
Although, the clustering hypothesis is consistent with the AFM results, an 
electrostatic repulsion hypothesis was also considered to explain the data in Figure 2.4.  
It should be noted, however, that an electrostatic effect seems implausible on several 
other grounds.  First, electrostatic repulsion between the negatively charged GM1 
glycolipids and the CTB proteins would probably not be expected to show the type of 
saturation behavior found in Figure 2.4.  Moreover, the Debye length is already rather 
short at the lower salt concentration employed in these experiments (~ 0.8 nm for 150 
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mM NaCl).138  This means that an incoming CTB molecule should not experience 
significant electrostatic repulsion from the charge on the membrane. 
Nevertheless, we wished to test the electrostatic hypothesis.  To do this, we 
monitored CTB binding in the presence of PBS buffer with a higher NaCl concentration 
(300 mM).  Under these conditions one might expect the apparent dissociation constant 
to tighten if electrostatic repulsion were playing a significant role in the effects observed 
in Figure 2.4.  Our results, however, showed no evidence for a change in the binding 
constant at higher salt concentration.  This was true even when 10.0 mol% GM1 was 
present in the membrane.  In fact, KH was measured to be 0.62 nM for 10.0 mol% GM1 
in the presence of 300 mM NaCl.  This value is identical within experimental error to the 
value obtained in Table 2.1 with 150 mM NaCl (0.59 nM).  Illustrative data are shown in 
Figure 2.8.  This plot shows the line profile of the fluorescence intensity across a seven-
channel microfluidic device containing POPC membranes with 10.0 mol% GM1.  The 
first three channels show data at various concentrations of CTB in the presence of PBS 
buffer with 300 mM NaCl, while the last three channels are for the identical conditions, 
but employing buffer with 150 mM NaCl.  As can be seen, the fluorescence intensities 
are virtually unaffected by the increase in salt. 
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Figure 2.8. Line profile of the TIRF intensity across a seven-channel, bilayer-coated 
microfluidic device containing 10.0 mol% GM1.  6.0 nM, 0.6 nM, and 0.12 nM CTB 
solutions containing 300 mM NaCl were flowed through the first three channels, 
respectively.  Similar samples in the reverse order with 150 mM NaCl were flowed 
through the last three channels.  The channel in the middle was filled with PBS buffer 
and used as a reference for determining the background level. 
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Discussion 
The effect of ligand density on CTB-GM1 binding presented here is opposite to 
that which would be predicted by a simple non-cooperative sequential binding model 
(eqn. 1).  In the absence of interacting ligands, steric/allosteric effects, or other related 
phenomena, one would expect that increasing ligand density at the membrane interface 
would strengthen ligand-receptor binding as was previously found in the case of 
antibody-antigen interactions.16  Herein, however, increased GM1 density in the 
phospholipid membrane actually led to a weakening of the apparent equilibrium binding 
constant.  This effect is almost certainly caused by interactions between the ganglioside 
molecules, which induced GM1 clustering on the solid-supported phospholipid 
membranes. 
The crystal structure of the CT-GM1 binding complex has been investigated by 
Merritt139 and isothermal titration calorimetry investigations have been performed by 
Turnbull.140  These studies show that the binding site specificity of cholera toxin for 
GM1 arises from recognition of the sialic acid, terminal galactose, and N-
acetylgalactosamine moieties.  Specifically, the majority of CTB-GM1 interactions 
involve hydrogen bonds to the sugar hydroxyl groups.  The clustering found in our AFM 
images suggests that at least some of these moieties may be involved in hydrogen bond 
formation with neighboring GM1 molecules.  This idea is further supported by EPR 
experiments of GM1 in phospholipid membranes, which indicated that the 
oligosaccharide head group is capable of forming intermolecular H-bonds.141  Hydrogen 
bonding between membrane bound GM1 molecules in model membranes has also been 
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suggested on the basis of freeze-etch electron microscopy.142  In the present experiments, 
such lateral interactions should effectively compete with the binding of the CTB 
proteins.  Moreover, the crowding of the GM1 molecules may limit CTB binding on 
steric grounds.  The putative mechanism for these effects is presented in Figure 2.1.   
It is interesting to note that previous studies have concluded that GM1 enriched 
lipid raft domains are needed to ensure maximal binding of CT to the cell surface.143,144  
Wolf et al.145 proposed that toxin-induced signal transduction depends on the coupling of 
CT with GM1 enriched caveolae or caveolae-like membrane domains.  No results to 
date, however, have shown stronger binding of CT to GM1 enriched raft domains.  The 
results in this chapter indicate that GM1 domain clustering may not strengthen toxin-
ligand interactions.  Rather, higher GM1 concentrations would simply lead to greater 
number densities of toxin molecules bound in these locations.  It should be noted, 
however, that cell membranes typically included other lipids such as sphingolipids and 
cholesterol which could possibly play a role in GM1 presentation and, hence, in the 
thermodynamics of cholera toxin binding. 
 
Conclusion 
Systematic studies of multivalent CTB-GM1 interactions in Chpater II were 
undertaken as a function of ligand density by using a microfluidic strategy in 
conjunction with TIRFM.  CTB bound more weakly at higher ligand densities and this 
observation was ascribed to the clustering of GM1 in the phospholipid bilayer.  AFM 
results supported this hypothesis.  Furthermore, characteristic equilibrium dissociation 
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constant measurements for GM1 clustering on solid-supported phospholipid membranes 
were determined. 
 
 40
CHAPTER III 
MULTIPLE MULTIVALENT LIGAND-RECEPTOR INTERACTIONS 
MEASUREMENT WITHIN ONE-SHOT BINDING EXPERIMENTS 
 
Introduction 
Multivalent ligand-receptor interactions are ubiquitous on cell surfaces.  They 
have a wide variety of consequences including enhanced binding, greater receptor 
selectivity, and receptor clustering.97  They can also play a direct role in signal 
transduction processes.146  Examination of the underlying thermodynamics of 
multivalency may lead to a greater understanding of its biological role and could provide 
insight into biomedical applications involving inhibitory drug design.97,99,104  
Unfortunately, high-throughput, low protein consumption assays are not presently well 
enough developed in this field to afford rapid, accurate systematic studies of ligand-
receptor binding at membrane interfaces in a systematic fashion.16   
In previous work our laboratory demonstrated that microfluidic devices can be 
designed for measuring binding affinities in multivalent systems at lipid membrane 
interfaces.15,16,34,92-94  In our setup, ligands were incorporated into supported lipid 
bilayers (SLBs) coated on the walls and floors of polydimethylsiloxane/glass 
microchannels.  Linear arrays of channels were then monitored by total internal 
reflection fluorescence microscopy (TIRFM)128 to obtain equilibrium dissociation 
constants in one-shot assays.  This could be done by using the same surface chemistry in 
each microchannel while varying the solution concentration of the aqueous proteins.  
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This made these assays more rapid, afforded high accuracy, and used only a few 
microliters of protein solution.  Nevertheless, these assays could still be improved 
considerably by measuring multiple binding constants for various membrane chemistries 
simultaneously.  This could be done by employing a variety of different lipid bilayer 
chemistries in each microfluidic channel while still arraying the solution concentration 
of the aqueous protein over the entire array.  This would essentially amount to a two-
dimensional assay whereby both the surface chemistry and aqueous solutions are varied 
on a single chip.  Such assays would be extremely useful for probing multivalent binding 
as a function of ligand density, cholesterol content, membrane charge, etc. in one-shot 
experiments.  Such designs are also reminiscent of other on-chip two-dimensional 
assays.147-149   
The key to achieving two-dimensional binding assay is to create spatially 
addressed arrays of bilayers inside individual microchannels.  There have already been a 
number of techniques developed to array different bilayer chemistries at each address.  
For example, we first showed the use of pulled microcapillaries to deliver unique vesicle 
solutions to an array of hydrophilic patches arrayed on a substrate with hydrophobic 
barriers.18  Subsequently, other methods for creating spatially addressed bilayer arrays 
have been developed.  These include microcontact printing,73-75 laminar flow vesicle 
deposition,84 mechanical erasing and writing,70 robotic pin printing,78 scanning probe 
lithography,85 and dip-pen nanolithography.82  Although each of these techniques has its 
merits, it would be most convenient to develop a procedure that allows bilayers to be 
arrayed inside enclosed microchannels with a well characterized and predetermined 
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chemistry at each location.  The most attractive way of obtaining such a result will be to 
develop a light directed patterning method analogous to the ones we have already 
developed for arraying immobilized ligands inside microfluidic devices.150  
Pioneering work has been done by the Parikh laboratory to pattern solid 
supported lipid bilayer using deep UV radiation.79,80,127,151  Additional with UV radiation 
had been undertaken to pattern organosilane monolayers152,153, polysaccharides,54 and S-
layer proteins.154  Chapter III extends this idea to patterning sacrificial adsorbed protein 
layers at the liquid/solid interface.  We show it is possible to deposit films made from 
bovine serum albumin (BSA), immunoglobulins, and fibrinogen.  Areas containing the 
protein layer resist the fusion of vesicles to form fluid lipid bilayers, while irradiated 
regions allow bilayers to form.  We exploited this ability to pattern linear arrays of 
phospholipid membranes containing four different concentrations of ganglioside GM1 
(Figure 3.1).  Each channel in a seven-channel device contained the same four 
membranes.  At this point, a unique concentration of cholera toxin B subunits (CTB) 
was flowed into each channel to yield 28 simultaneously data points for the CTB-GM1 
binding pair.  This afforded multiple equilibrium dissociation constants for ligand-
receptor binding on fluid phospholipid membranes.   
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Figure 3.1.  Schematic representation of the general process steps for creating spatially 
addressed bilayer arrays.  A sacrificial protein monolayer was patterned in a single 
microchip or individual microfluidic channels by deep UV radiation.  SLBs were formed 
by vesicle fusion.  The solid substrate is 0.2 mm thick quartz. 
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Experimental 
Materials Bovine serum albumin (BSA), Texas Red conjugated BSA, 
Rabbit IgG, and Texas Red-labeled 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, triethylammonium salt (TR-DHPE) were purchased from 
Molecular Probes, Inc. (Eugene, OR).  Fibrinogen from human plasma and CTB from 
Vibrio cholerae were obtained from Sigma-Aldrich.  Ganglioside GM1 (Brain, Ovine-
Ammonium Salt), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), and 1,2-
Dipalmitoyl-sn-Glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) 
(Ammonium Salt) (NBD-PE) were purchased from Avanti Polar Lipids (Alabaster, AL).  
CTB was labeled with Alexa Fluor-594 dye using a standard protein-labeling kit 
(A10239, Molecular Probes, Eugene, OR).  The degree of labeling was about 0.8 
fluorophores per protein as determined by UV/Vis absorption spectroscopy.  The dye-
labeled protein was stored in PBS buffer solution containing 10 mM sodium phosphate, 
150 mM NaCl, and 0.2 mM sodium azide.  The pH of the PBS was set to 7.2 by 
dropwise addition of 2.0 M NaOH.  The PBS buffer was also used for vesicle 
preparation and the successive dilution of protein solutions.  Purified water for these 
experiments came from a NANOpure Ultrapure Water System (≥18.2 MΩ·cm, 
Barnstead, Dubuque, IA).  Quartz coverslips (1×1 inch, 0.2 mm thick, Electron 
Microscopy Sciences, Hatfield, PA) were used as substrates for lipid bilayer formation.  
Electron Microscope grids (EM-grids, Gilder Grids from Electron Microscopy Sciences, 
Hatfield, PA) were employed as photomasks in deep UV lithography.   
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Small Unilamellar Vesicles Preparation Small unilamellar vesicles (SUVs) 
was prepared by vesicle extrusion as reported previously.15,47,48  Briefly, lipids dissolved 
in chloroform were dried under a stream of nitrogen followed by vacuum desiccation for 
4 hours.  The lipids were then rehydrated in PBS buffer.  The concentration of lipids in 
solution was 2.0 mg/mL.  After five freeze-thaw cycles the vesicles were extruded more 
than seven times through a polycarbonate filter (Whatman) with 50 nm pores.  SUVs 
prepared by this method were characterized by dynamic light scattering (90Plus particle 
size analyzer, Brookhaven Instruments Corp.) and showed a size of 70 ± 10 nm in 
diameter.  Sample vesicles include pure POPC, TR-DHPE/POPC mixtures with 0.5 - 
0.05 mol% TR-DHPE, NBD-PE/POPC mixtures with 2 mol% and 0.5 mol% NBD-PE, 
and GM1/POPC mixtures containing 0.2 mol%, 0.5 mol%, and 2.0 mol% GM1, 
respectively. 
 
Microfluidic Device Fabrication The seven-channel microfluidic devices 
were fabricated as described previously.34  The only difference is that we used 0.2 mm 
thick quartz substrate, instead of borosilicate glass.  Basically, we fabricated the seven-
channel geometry pattern on cleaned soda lime microscope slides by photolithography 
and buffered oxide etchant (BOE) etching.  Degassed PDMS was then poured over the 
glass master and cured in a convection oven at 55 °C overnight.  The elastomeric mold 
was carefully peeled off, washed with ethanol and purified water, and dried under a 
stream of nitrogen.  Inlets were reamed at the channel termini using a hollow flat-tipped 
syringe needle.  Finally, the PDMS mold and a clean planar quartz coverslip were 
 46
treated in an oxygen plasma for 30 s.  The two were brought immediately into contact to 
create the finished microfluidic device.  It should be noted that the quartz substrate was 
cleaned in a boiling 1:3 solution of ICN x7 detergent and purified water.  It was then 
rinsed with copious amounts of purified water, dried with nitrogen, and annealed in a 
kiln at 500 °C for 5 hours before use.   
 
Epifluorescence and TIRF Microscopy Epifluorescence images of protein 
patterns and SLBs were obtained using a Nikon E800 fluorescence microscope with a 
Roper Scientific Micromax CCD camera.  To check the quality and fluidity of the SLBs, 
Fluorescence Recovery after Photobleaching (FRAP)125,126 experiments were conducted 
using an inverted epifluorescence Nikon Eclipse TE2000-U microscope with a 10× 
objective.  Laser radiation from a 2.5 W mixed gas Ar+/K+ laser (Stabilite 2018, Spectra 
Physics) was used to bleach the lipid bilayer samples.  FRAP images were obtained with 
a MicroMax 1024b CCD camera (Princeton Instruments).  Total internal reflection 
fluorescence (TIRF) microscopy128 was employed in CTB-GM1 binding studies as a 
function of ligand density.  In the TIRF microscopy experiments, a 594 nm Helium-
Neon laser beam (4 mW, Uniphase, Manteca, CA) was passed through a dove prism that 
was optically coupled to the quartz substrate of the microfluidic device by index 
matching immersion oil.  The laser beam was telescoped out by a line generator lens 
(BK7 for 30°, Edmund Optics, Barrington, NJ) to create a uniform intensity profile 
across the microchannel array.  As the laser illuminated the interface between the quartz 
substrate and the bilayer, it was internally reflected, creating an evanescent wave above 
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the interface.  The evanescent wave decayed exponentially to its 1/e value by ~ 70 nm 
from the interface under the experiment conditions employed here.15,130  This allowed 
the proteins bound to the SLBs to be studied with high specificity.  All images were 
collected using Metamorph software (Universal Imaging Corp.) and transferred to 
Microsoft Excel and Sigma Plot for further processing. 
 
Results 
In a first set of experiments, we wished to test the use of a bovine serum albumin 
(BSA) as a sacrificial protein monolayer in deep UV patterning experiments.  To this 
end, a 10 mg/mL solution of BSA was introduced above a quartz surface and allowed to 
incubate for 20 min.  This should form a continuous monolayer of BSA at the 
interface.155  Excess proteins were washed away with copious amounts of purified water.  
The protein was conjugated with a Texas Red fluorophore so that it could be visualized 
under a fluorescence microscope.  Electron Microscope grids (EM-grids) were exploited 
as a photomask for photopatterning.  Deep UV radiation was produced by a mercury 
Pen-Ray lamp (UVP Inc., Upland, CA) in a quartz envelope.  The protein-coated 
substrate was placed ~ 3 mm under the UV light source.  The BSA monolayer could be 
either under water or exposed to air.  ~ 2.8 W of radiation with wavelengths of ~ 190 nm 
and ~ 254 nm was introduced to the sample surface through a photomask for 2 min.  The 
surface was then washed with copious amounts of D.I. water.   
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Figure 3.2. (a) Epifluorescence image of Texas Red-conjugated BSA protein pattern.  
(b) Epifluorescence image of POPC bilayer containing 2.0 mol% NBD-PE formed over 
deep UV exposed regions.   
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Figure 3.2a shows the resultant pattern formed on the substrate.  Specifically, ~ 
90 × 90 µm voids were created which were separated by ~ 35 µm protein bars.  This was 
identical to the dimensions of the 200 mesh EM-grid used to make the pattern.  At this 
point, POPC vesicle solutions containing 2 mol% NBD-PE/POPC were introduced 
above the patterned surface and allowed to form bilayers by the vesicle fusion method.9  
This led to the creation of patterned POPC membranes separated by BSA barriers 
(Figure 3.2b).  The high contrast epifluorescence image consisting of green lipid bilayers 
and dark bars demonstrates that SLBs were confined in the protein corrals.156  The two-
dimensional fluidity of the bilayer microarray was confirmed by the fluorescence 
recovery after photobleaching technique125,126 (Figure 3.3).  The diffusion constant for 
the NBD-PE lipid was 3.4 ± 0.8 µm2/s and the mobile fraction was ~ 97%.   
Next, it was necessary to demonstrate that this method could be used as a 
sequential patterning technique.  The ability of the present method for spatial addressing 
a bilayer array with different lipid components was created in a single microchip or 
individual microchannels.  The general steps were illustrated in Figure 3.1.  Basically, 
after deep UV illumination through a single slot EM-grid photomask (hole size: ~ 100 
µm), BSA under light exposure was selectively removed to form a round vacancy on the 
substrate.  A supported lipid bilayer was then addressed over the light exposed region 
through vesicle fusion.  In the second step, the photomask is manually aligned to another 
unexposed protein region.  Repeating the erasing and addressing step, second supported 
lipid bilayer was deposited into the new vacancy.  Multiple distinct lipid components can  
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Figure 3.3.  FRAP recovery curve for 0.1 mol% TR-DHPE/POPC bilayer on a planar 
borosilicate substrate.  Inset is the fluorescence images right after photobleaching and 
after recovery. 
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Figure 3.4.  (a) Epifuorescence image of a single microchip containing various lipid 
compositions (top left: 0.5 mol% TR-DHPE/POPC, top right: 0.1 mol% TR-
DHPE/POPC, bottom left: 2.0 mol% NBD-PE/POPC, and bottom right: 0.5 mol% NBD-
PE/POPC).  (b) Epifuorescence image of SLBs array addressed in three microchannels.  
The three lipid bilayer regions are 0.5 mol%, 0.2 mol%, and 0.05 mol% TR-
DHPE/POPC from left to right.  Scale bar is 200 µm. 
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be spatially addressed into a single microchip by repeating this process.  Figure 3.4a 
shows the epifluorescence image of four 99 ± 4 µm circles addressed with four 
chemically different lipid bilayers, including 0.5 mol% TR-DHPE/POPC, 0.1 mol% TR-
DHPE/POPC, 2.0 mol% NBD-PE/POPC, and 0.5 mol% NBD-PE/POPC.   
By using the same strategy, SLBs with different components can also be spatially 
addressed into individual microfluidic channels.  Microfluidic devices are consisted of 
PDMS molds and quartz substrates.  It should be noted that instead of glass, quartz is 
used as the substrate of microfluidic device since deep UV at ~ 190 nm, which is 
necessary for protein ablation, cannot penetrate through PDMS and glass.  Protein 
solutions were injected into four individual microchannels and allowed to incubate for 
20 min to form a thin protein film coating on quartz surface and PDMS walls.  After 
incubation, purified water was flushed through the channels to remove excess proteins.  
Next, deep UV radiation was passed through a photomask localized on bottom of the 
microfluidic device as shown in Figure 3.1.  The photomask was made by bringing two 
glass coverslips close to each other over a quartz substrate.  The slit between the two 
glass coverslips is ~ 450 µm wide.  Thus deep UV can pass through the slit, but is 
otherwise completely absorbed by glasses.  After removing the proteins exposed to deep 
UV, vesicle solution was injected into the microchannels.  Vesicle fusion occurred on 
both the PDMS walls and the glass substrate to form a continuous lipid bilayer coating.17  
The incubation time for bilayer formation was 5 min.  The microchannels were rinsed 
with PBS buffer to remove excess vesicles.  By repeating these steps, three different 
lipid bilayers were patterned inside four microchannels as illustrated in Figure 3.4b.  The 
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three lipid bilayers are 0.5 mol%, 0.2 mol%, and 0.05 mol% TR-DHPE/POPC from left 
to right.   
To prove such SLBs spatially addressed microfluidic device is suitable for 
multiple multivalent ligand-receptor interactions measurement simultaneously, 
pentavalent CTB-GM1 system was chosen as a demo.  The microfluidic device was 
fabricated from quartz substrate and PDMS mold with seven microchannels.  Each 
microchannel was spatially addressed with four POPC bilayer regions containing 0 
mol%, 0.2 mol%, 0.5 mol%, and 2.0 mol% GM1 ligand from left to right as shown in 
Figure 3.5a.  TIRF microscopy was applied to study the pentavalent CTB-GM1 
interactions as a function of ligand density.  Before the injection of protein solution, the 
bilayer-coated microchannels were incubated with a 0.5 mg/mL Rabbit IgG antibody 
solution for 30 min to block defect sites in the membrane and thereby suppress non-
specific adsorption of CTB.  Next, Alexa 594-labeled CTB solutions were flowed 
through each channel at various concentrations, simultaneously at a rate of 0.2 µL/min.  
The surface binding process was monitored by TIRF microscope as a function of time 
until the fluorescence intensity remained constant.  A typical TIRF age is shown in 
Figure 3.5a.  In this case the bulk CTB concentration ranged from 0.09 nM to 2.15 nM 
(top to bottom).  Pure POPC bilayers outlined with the first red rectangle on left, was 
used as a background control.  Under the present conditions, virtually no background 
fluorescence signal was observed, as the bulk protein concentrations were so low.34,115  
Intensity profiles across the TIRF image (red rectangles shown in Figure 3.5a) were 
employed to obtain quantitative binding data.  Figure 3.5b shows the binding  
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Figure 3.5.  (a) TIRF image of lipid bilayers-coated microchannel array containing 
various concentrations of dye-labeled CTB.  Lipid bilayers highlighted in four red 
rectangles from left to right are pure POPC, GM1/POPC containing 0.2, 0.5, and 2.0 
mol% GM1, respectively.  (b) Fluorescence signal vs. bulk CTB concentration in 
supported POPC membranes containing 2.0 (square), 0.5 (triangle), 0.2 (circle) mol% 
GM1.  The curves were fit to the Hill-Waud equation. 
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results on supported POPC membranes containing 2.0 mol%, 0.5 mol%, and 0.2 mol% 
GM1.   
To abstract equilibrium dissociation constant data from the CTB-GM1 binding 
data, the curves were fit to Hill-Waud (eq 1) binding model34,94,122: 
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where F is the fluorescence intensity from surface bound proteins, Fmax is the maximum 
fluorescence intensity when proteins completely saturated the bilayer surface, [P] is the 
bulk CTB concentration, Kd is the apparent equilibrium dissociation constants, and n is 
the Hill coefficient of cooperativity.122  In our previous work34, this binding model was 
found to be more suitable to pentavalent CTB-GM1 interaction compared with Langmuir 
adsorption isotherm model.  The Hill-Waud model was also used by other groups, and 
proved to be good at fitting CTB-GM1 binding data.94,122  The apparent dissociation 
constants Kd extracted from Figure 3.5b are 0.20 nM, 0.29 nM, and 0.35 nM for 0.2 
mol%, 0.5 mol%, and 2.0 mol% GM1/POPC, respectively.  The binding results are in 
good agreement with our previous study of CTB-GM1 interaction.34  Also it can be 
found that the apparent dissociation constant weakens as a function of GM1 density in 
the POPC bilayer.  Such effect of ligand density on CTB-GM1 interaction was 
contributed to the clustering of GM1 in the supported phospholipid membranes, which in 
turn inhibits the binding of CTB.  GM1 clustering was directly verified by atomic force 
microscopy (AFM) experiments.34   
In this binding study, two things should be noted.  One thing is the spontaneous 
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lipid transfer between existed supported lipid bilayers and vesicles for subsequent lipid 
bilayer formation.157  If such transfer happens very quickly during the patterning of 
supported GM1/POPC bilayer arrays in microchannels, GM1 density in POPC bilayers 
should thus be calibrated.  To check the effect of lipid transfer, one control experiment 
was conducted by incubation of pure POPC vesicle solution with solid supported 0.1 
mol% TR-DHPE/POPC bilayers for 1 hour which is longer than the time necessary for 
GM1/POPC bilayer array formation in microchannels.  Then bulk vesicle solution was 
rinsed with copious PBS buffer.  The fluorescence intensity of supported lipid bilayer 
before incubation and after 1 hour incubation showed no difference.  This result suggests 
that spontaneous lipid transfer is negligible for SLBs microarray formation and 
multivalent interactions under the present experimental conditions. 
 
Discussion 
Besides BSA, other proteins such as IgG and fibrinogen can also be selectively 
removed from solid substrates by deep UV radiation and used as sacrifice layers for 
SLBs spatial addressing.  Although other strategies including microcontact printing156, 
micro-electrochemical lithography158, nanoshaving lithography159, and 
photolithography160,161 have been developed for protein patterning on solid substrates, 
they need to use PDMS molds, electrodes, AFM tips, or photoactive moieties.  
Compared to these methods, deep UV lithography for protein patterning is relatively 
elegant, simple, and easy to control.  It should be noted that deep UV at ~ 190 nm is 
necessary for the degradation of proteins.   
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The working mechanism of deep UV for photochemical degradation of proteins 
could contribute to the high energy (~ 150 kcal/mol) of photons at the wavelength of ~ 
190 nm, since the energy is higher than most of the single bonds and multiple bonds of 
proteins.  The energy of UV with higher wavelength (e.g. 254 nm) is not high enough to 
crack the chemical structure of proteins such as BSA.  This mechanism can be proved by 
switching the quartz substrate over which photomask is coated to glass or PDMS.  In 
Figure 3.6a, UV-Vis spectra show that quartz is transparent to UV down to 190 nm, UV 
above 240 nm can pass PDMS, and glass almost blocks most of the UV light.  By 
conducting the experiment as illustrated in Figure 3.1 with different photomask 
substrates, results showed that dye-labeled BSA pattern could only be created by using 
quartz photomask substrate.  It means that deep UV at ~ 190 nm is necessary for the 
ablation of proteins.  Figure 3.6b demonstrates that after 2 min exposure to deep UV, the 
BSA monolayer can be removed.  This result is consistent with previous reports that 
deep UV at ~ 190 nm can be used to degrade organosliane monolayers152,153 and S-layer 
proteins154.   
Another ablation mechanism in the case of lipid bilayers was proposed by Parikh 
and colleagues.79,80  They mentioned that two wavelength, ~ 185 nm and ~ 254 nm, of 
the mercury lamp are both relevant to the photodegradation process.  Strong oxidizing 
agents including ozone and singlet molecular oxygen (1O2*) were created after the ~ 185 
nm wavelength was absorbed by O2 in the solution.  Lipid molecules were excited by 
absorbing ~ 254 nm wavelength to produce ions, free radicals, and excited molecules.  
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Figure 3.6.  (a) UV-Vis spectra of quartz, PDMS, and glass.  (b) UV-Vis spectra of BSA 
monolayer-coated quartz before (solid line) and after 2 min deep UV exposure (dash line). 
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Figure 3.7.  Epifluorescence image of 0.1 mol% TR-DHPE/POPC bilayer microaaray 
with different deep UV exposure time: (a) 0, (b) 30, (c) 120, (d) 180, (e) 300, (f) 450 sec. 
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When the activated species were reacted with 1O2* and O3, lipid molecules were 
degraded and dissolved in the solution.  Real-time ATR-FTIR spectroscopy was used to 
monitor the products of the deep UV-induced lipid degradation.79,80  
It should be also noted that radiation exposure time is the key parameter for 
uniform lipid bilayer formation.  Results in Figure 3.7 show epifluorescence images of 
TX-DHPE/POPC bilayer as a function of exposure time.  Figure 3.7a shows that without 
deep UV exposure, SLBs cannot form on BSA monolayer.  When the exposure time is 
not enough, BSA cannot be fully degraded, and the quality of SLBs is not good.  When 
the BSA monolayer is overexposed, lipid vesicles adsorbed on the boundaries can be 
observed (Fiugre 3.7d and 3.7e).  The reason may be contributed to the low collimation 
quality of deep UV light from mercury Pen-Ray lamp.  Then BSA under photomask-
covered regions will be partially degraded by the deep UV radiation and induces the 
adsorption of lipid vesicles.  When the exposure time further increased, uniform lipid 
bilayer can form on the whole substrate without any pattern.  Scratches in Figure 3.7f 
were made by a sharp needle for image focusing.  Uniform lipid bilayer patterns can 
only be obtained under the optimal conditions as shown in Figure 3.7c.  This parameter 
will vary from different proteins.   
 
Conclusion 
This chapter developed a novel technique for spatial addressing of SLBs in a 
single microchip or individual microfluidic channels using a protein sacrifice layer.  
These arrays could, in turn, be employed in high throughput assays for biosensing, 
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enzyme kinetics, and multivalent ligand-receptor isotherms.  In fact, in conjunction with 
TIRFM, multiple equilibrium dissociation constants were abstracted from one-shot 
binding experiments.  Other advantages include low protein consumption and 
elimination of experimental errors.  Besides, with the size reduction of lipid bilayer 
regions in microchannels, more binding curves could be obtained simultaneously.  And 
if different kinds of ligands were addressed in one assay, numerous ligand-receptor 
interactions could be compared, not necessarily limited to multivalent events.   
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CHAPTER IV 
CHARACTERIZATION OF PHOSPHATASE ENZYME TETHERED TO 
SUPPORTED LIPID BILAYERS: EFFECT OF ENZYME SURFACE DENSITY 
 
Introduction 
Enzyme immobilization on various surfaces has gathered great attention for its 
numerous applications on biosensors, bioreactors, bioelectronics, biofuel cells, 
immunoassays, etc.160,162,163  The integration of enzymes with solid supports has been 
achieved by many technologies, which can conveniently be divided into three 
categories.160,164  Adsorption immobilization can non-covalently assemble enzymes to 
surfaces by electrostatic, hydrophobic, and hydrophilic interactions.  This method is 
simple, but suffers from nonspecific binding and enzyme leakage from substrates.  
Chemical immobilization methods involve the formation of covalent binding between 
enzymes and support materials.  For example, amino, hydroxyl, and carboxyl groups on 
enzyme surfaces are often used in the attachment to supports containing different surface 
functional groups (carboxylic acid, amine, lactone, thiol, etc.).  Affinity interactions, 
such as antigen-antibody and biotin-avidin (streptavidin) binding, provide a different 
technique for enzyme immobilization.  Recently, our group utilized biotinylated 
phospholipid bilayers and protein layers photoattached with biotin-linked dye to 
immobilize and characterize avidin (streptavidin)-conjugated enzymes in microfluidic 
systems.17,150   
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Compared with enzymes in free solution, surface-immobilized enzymes have 
some prominent features, such as easy separation of the enzyme and the reaction 
product, and continuous re-use.  However, immobilization often affects the stability and 
activity of the enzyme.  The turnover number of enzymes upon immobilization could be 
reduced several folds to ~ 30 times relative to the soluble enzymes.17,165-170  Several 
factors may contribute to the loss of enzyme activity, including partial enzyme 
denaturation, steric effects, enzyme orientations, and immobilization matrix 
microenvironment effects.  To improve the immobilized enzyme activity, a lot of efforts 
have been made, such as controlling orientation of the linked enzyme, reducing 
nonspecific absorption, increasing distance between enzyme and substrate using a spacer 
arm, etc.166,171-175  These strategies can reduce the steric hindrance and improve the 
substrate accessibility of enzyme catalytic sites. 
Beyond the above efforts, few studies have been done to probe the effect of 
surface density of immobilized enzyme on its catalytic efficiency and turnover number, 
although surface density may affect the enzyme distribution, flexibility, lateral 
interactions, etc.  DeLouise and Miller168 covalently immobilized two different 
concentrations of glutathione-S-transferase (GST) on porous silicon films and measured 
the kinetic parameters.  Results showed that the turnover rate is independent of the 
enzyme surface density, although the turnover number of immobilized GST is ~ 5 times 
lower than that of the free enzyme in solution.  Xu et al.167 utilized surface plasmon 
resonance spectroscopy and fiber optic absorbance spectrometer to monitor the 
enzymatic activity of biotin-β-lactamase immobilized on NeutrAvidin-functionlized 
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chip.  Kinetic parameters of surface-linked enzyme with three different enzyme surface 
coverages were obtained.  The catalytic efficiency of the enzyme at low surface density 
is ~ 2 and ~ 9 times higher than that at medium and high surface density, but the 
turnover rate at three different densities shows little difference.  Caseli et al.170 reported 
the adsorption of three different densities of detergent-solubilized alkaline phosphatase 
onto dimyristoyl phosphatidic acid Langmuir-Blodgett films.  Catalytic activity of the 
immobilized phosphatase with different surface densities was compared by measuring 
the conversion rate of 1 mM substrate of para-nitrophenyl phosphate.  An increase of 
enzymatic activity was found as the enzyme surface density decreases.  However, kinetic 
parameters including turnover number and catalytic efficiency were not provided in the 
work.  These results inspired us to conduct a systematic study of surface density effects 
on enzyme activity.   
In this chapter, we employed biotinylated phospholipid bilayers to immobilize 
streptavidin-conjugated alkaline phosphatase in microfluidic channels.  Such biotin-
streptavidin immobilization matrix in conjunction with supported lipid bilayers (SLBs) 
will provide some benefits.  First, nonspecific absorption of phosphatase on supported 
lipid bilayers is tiny and lipid bilayer serves as a cushion to prevent the enzyme 
denaturation upon immobilization.17  Second, an uniform oriented protein film could be 
generated without requiring a close packed monolayer on SLBs surface.176 Third, 16:0 
N-Biotinyl-Cap-PE and biotin-streptavidin linker provide a good space arm to facilitate 
the substrate access of enzyme active sites.  Fourth, with two-dimensional fluidity of the 
lipid bilayer on solid supports, immobilized enzymes can be well organized on bilayer 
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surface, and keeps mobile at low enzyme surface density.  Besides, microfluidic devices 
made of glass and poly-(dimethylsiloxane) (PDMS) offer high-throughput capabilities 
and extremely low sample consumption, and can serve as supports for SLBs formation.15   
To obtain enzyme turnover rates, catalytic efficiency, and other kinetic 
parameters under different enzyme surface densities, 4-methylumbelliferyl phosphate 
(MUP) was utilized as substrate for dephosphorylation.  Biotinylated POPC bilayer was 
formed in microchannels by vesicle fusion method.17,21  Alkaline phosphatase density on 
membrane surface can be controlled by changing the biotin-cap-PE percentage in POPC 
bilayers.  Conversion rate of blue fluorescent product of 7-hydroxy-4-methylcoumarin 
(HMC) was recorded by Epifluorescence microscopy.  Kinetic parameters were 
extracted using Lineweaver-Burk equation.177  In addition, enzyme kinetics in free 
solution was also measured using the same microfluidic devices.  Results indicate higher 
turnover rate and catalytic efficiency at low enzyme surface densities than at high 
densities, although the enzyme in solution shows the highest activity.  Turnover rate and 
enzymatic efficiency increasing at low enzyme surface densities could be explained by 
low steric crowding hindrance and high enzyme fluidity, as well as the resulting 
improvement of substrate accessibility and affinity of enzyme catalytic sites.   
 
Experimental 
Materials Texas Red-labeled streptavidin, streptavidin-cojugated alkaline 
phosphatase (1:1 stoichiometry), 4-methylumbelliferyl phosphate (MUP), Texas Red-
labeled 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt 
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(TR-DHPE), and Fibrinogen were purchased from Molecular Probes, Inc. (Eugene, OR).  
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 16:0 N-Biotinyl-Cap-PE 
were obtained from Avanti Polar Lipids (Alabaster, AL).  High blue fluorescent 7-
Hydroxy-4-methylcoumarin (HMC), product of MUP dephosphorylation, was from 
Fisher Scientific.  Borosilicate glass coverslips (VWR Scientific, No. 1, 22 × 22 mm) 
were used as microchannel substrates for lipid bilayer formation.  PBS buffer solution 
(20 mM sodium phosphate, 150 mM NaCl, 0.2 mM sodium azide, and titrated to pH 7.2 
with 2.0 M NaOH) was used for vesicle preparation.  MUP and HMC solutions were 
prepared using carbonate buffer (pH 9.8, 50 mM Na2CO3, 50 mM NaHCO3, ionic 
strength 150mM).  Purified water for these experiments came from a NANOpure 
Ultrapure Water System (≥18.2 MΩ·cm, Barnstead, Dubuque, IA).   
 
Small Unilamellar Vesicles Preparation Small unilamellar vesicles (SUVs) 
was prepared by vesicle extrusion as reported previously.15,47,48  Briefly, phospholipids 
were dissolved in chloroform with the desired molar ratio.  Bulk chloroform was dried 
under a stream of nitrogen and evaporated under vacuum overnight.  PBS buffer (pH 
7.2) was then added to the dried lipids to yield a lipid concentration of 2.5 mg/ml.  After 
rehydration, the lipid samples were subject to at least five freeze-thaw cycles, and 
extruded more than seven times through a polycarbonate filter (Whatman) with 50 nm 
pores.  SUVs prepared by this method were characterized by dynamic light scattering 
(90Plus particle size analyzer, Brookhaven Instruments Corp.) and showed a size 
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distribution of 70 ± 10 nm in diameter.  Sample vesicles include pure POPC, and 
biotin/POPC mixtures containing 0.01 mol% to 2.0 mol% biotin-cap-PE. 
 
SLBs Formation in Microfluidic Devices All enzyme kinetics experiments 
were conducted inside linear arrays of lipid bilayer-coated microchannels (Figure 4.1).  
Each channel was ~ 150 µm in width, ~ 20 µm in height, and separated from its 
neighbors by ~ 250 µm barriers.  The seven-channel microfluidic devices consisted of 
lithographically patterned PDMS molds (Dow Corning Sylgard Silicone Elastomer-184, 
Krayden, Inc.) and borosilicate glasses were prepared as previously described.15  Briefly, 
50 × 75 mm soda lime microscope slides were coated with a thin layer of 
hexamethyldisilazane (HMDS) to improve the adhesion of the photoresist to the glass 
surface,124 followed by spin coating with Shipley 1827 photoresist to a thickness of 10 
µm.  Photomasks were prepared by transferring the geometry of microfluidic channels 
onto photographic films.  The photoresist-coated substrates were then exposed using a 
Quintel 6000 mask aligner, treated with a 1:1 solution of Microposit developer 
concentrate (Microchem) and purified water, and baked at 120 °C overnight.  After post-
baking, the glass substrates were immersed in buffered oxide etchant (BOE) in an 
ultrasonic bath.  The etching process included 1.5 min etching in BOE, 30 sec dipping in 
a 1M HCl solution, and 30 sec rinsing with purified water.  This process was repeated 
seven cycles to get ~ 20 µm thick features.  The remaining photoresist was removed with 
ethanol after etching.  Inlet and outlet holes were punctured in to the PDMS for  
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7-hydroxy-4-methylcoumarin (HMC) 4-
methylumbelliferyl  
phosphate (MUP) 
Substrate 
Figure 4.1.  Schematic representation of seven-channel microfluidic device and 
streptavidin-conjugated alkaline phosphatase tethered to a biotinylated POPC bilayer.  
Channel 1 to 6 was filled with MUP solution with different concentrations and channel 7 
was filled with 1.0 mM HMC as standard.  For simplification, biotin molecules in the 
lower POPC leaflet were not drawn. 
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experimental purposes.  Degassed PDMS was then poured over the glass master and 
cured in a convection oven at 55 °C overnight.  The elastomeric molds, which bore the 
negative pattern of the master, were carefully peeled off and washed repeatedly with 
acetone and ethanol.  Finally, the PDMS mold and a clean planar glass coverslip were 
treated by oxygen plasma (plasma cleaner PDC-32G, Harrick Scientific, Ossining, NY) 
for 30 s and brought immediately into contact to create the finished microfluidic device.  
It should be noted that the borosilicate coverslips were cleaned in hot surfactant solution 
(ICN ×7 detergent, Costa Mesa, CA), rinsed with copious amounts of purified water, and 
then annealed in a kiln at 480 °C for 5 h before use.   
For SLBs formation, 5 µL of an SUV solution was injected through each inlet 
port of the linear array microfluidic device.  It should be noted that this was done 
immediately after plasma treatment to insure that the surfaces rendered hydrophilic.  
Supported lipid bilayers formed spontaneously on both the PDMS walls and the glass 
substrate via the vesicle fusion method.15,17  The incubation time for bilayer formation 
was 10 min.  The microchannels were rinsed with PBS buffer to remove excess lipid 
vesicles.  Fluorescence recovery after photobleaching (FRAP)125,126 was employed to 
verify the quality of the supported bilayers on the channel surfaces.   
 
Enzyme Immobilization SLBs containing biotin-cap-PE were first formed 
on the microchannel surfaces as described above.  A solution of 5 mg/mL Fibrinogen in 
PBS buffer was then injected and incubated for 30 min before it was washed out by 
carbonate buffer (pH 9.8).  This incubation step can passivate the defect sites in the 
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membrane and thereby suppress the nonspecific absorption of alkaline phosphatase.  
Next, a solution of 0.02 mg/mL streptavidin-conjugated alkaline phosphatase was 
flowed through each channel using a Harvard PHD 2000 syringe pump (Harvard 
Apparatus, Holliston, MA) at a rate of 0.05 µL/min for 30 min.  Total internal reflcection 
fluorescence (TIRF) experiments showed that biotin-streptavidin interaction could reach 
equilibrium under the above conditions.  Extra alkaline phosphatase was washed out 
with carbonate buffer (pH 9.8).  To obtain different enzyme surface densities, percentage 
of biotin-cap-PE in lipid membranes was changed from 0.01 mol% to 2.0 mol%.  
Alkaline phosphatase surface density, [E]s, on the bilayer can be estimated from the 
footprint size of crystalline streptavidin, POPC headgroup area, and percentage of biotin 
in POPC bilayers.   
 
Epifluorescence and TIRF Microscopy To check the quality and fluidity of 
supported lipid bilayers, FRAP studies were conducted using an inverted epifluorescence 
Nikon Eclipse TE2000-U microscope with a 10× objective.  Laser radiation from a 2.5 
W mixed gas Ar+/K+ laser (Stabilite 2018, Spectra Physics) was used to bleach the lipid 
bilayer samples.  FRAP images were obtained with a MicroMax 1024b CCD camera 
(Princeton Instruments).  FRAP experiments were also conducted to study the effect of 
biotin-cap-PE density on the mobility of streptavidin bound to lipid bilayers.  Enzyme 
kinetics in microchannels was obtained using an upright Nikon E800 fluorescence 
microscope with a 4× objective.  After the enzyme immobilization, the microfluidic 
device was placed under the microscope.  One Harvard PHD 2000 syringe pump was 
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employed to quickly infuse MUP solutions with different concentrations into the PDMS 
microchannels, simultaneously.  Once the microchannels were filled with MUP solution, 
the flowing was stopped immediately, and fluorescence change during 
dephosphorylation of MUP by immobilized alkaline phosphatase was recorded by Roper 
Scientific Micromax 1024b CCD camera.  Total internal reflection fluorescence 
(TIRF)128,129 microscopy was employed to study biotin-streptavidin binding for the 
estimation of the protein density on lipid bilayer surfaces.  TIRF can discriminate 
between dye-labeled streptavidin molecules bound to the supported membrane and those 
in the bulk solution.  This allowed the proteins bound to the supported lipid bilayer to be 
studied with high specificity.  All the fluorescence images were collected using 
Metamorph software (Universal Imaging Corp.) and transferred to Sigma Plot for further 
processing.   
 
Results 
Characterization of Immobilized Phosphatase For the characterization of 
surface immobilized alkaline phosphatase, 4-methylumbelliferyl phosphate (MUP) was 
chosen as the substrate for dephosphorylation, because MUP is only weakly fluorescent, 
but becomes strongly fluorescent in the blue visible light region upon 
dephosphorylation.  A schematic representation of the alkaline phosphatase-immobilized 
PDMS microchannels bonded to a planar glass support is shown in Figure 4.1.  The 
alkaline phosphatase was tethered to the lipid bilayers through biotin-streptavidin  
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Figure 4.2.  Time-lapse epifluorescence images revealing the conversion of MUP to 
HMC by the alkaline phosphatase tethered to the 0.08 mol% biotin/POPC bilayer.  The 
top first channel was filled with 1.0 mM HMC as standard.  Other six channels (top to 
bottom) were filled with MUP solution from 2.0 mM to 0.25 mM at 0 sec. 
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Figure 4.3.  (a) Fluorescence intensity of HMC produced in the first 20 sec from the 
dephosphorylation reaction in six microchannels in Figure 4.2.  (b) Lineweaver-Burk 
plot of the reciprocal initial reaction velocity obtained from (a) vs. the reciprocal of 
MUP substrate concentrations.   
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interaction.  The formation of HMC product was monitored by following the change in 
the blue fluorescence intensity as a function of time (Figure 4.2).  In this case, the 
concentration of MUP solution ranged from 0.25 mM to 2.0 mM (bottom to top, channel 
1 to 6 in Figure 4.1).  The supported POPC bilayers contained 0.08 mol% biotin-cap-PE.  
The top first channel (channel 7 in Figure 4.1) was filled with 1.0 mM HMC, product of 
dephosphorylation, as standard.  After ~ 200 sec, the enzymatic reaction reached 
equilibrium.  Comparing the maximum fluorescence signal from the channel filled with 
1.0 mM MUP with that from the standard channel, it can be found that the conversion of 
1.0 mM MUP to HMC is close to 100%.  The maximum fluorescence intensity from 
each channel showed linearly related to the initial MUP concentration, which is 
consistent with the control experiment using HMC solution at the same concentrations.  
This result revealed that the conversion of MUP under the experimental conditions is 
complete.   
The conversion of MUP to HMC was recorded by plotting the blue fluorescence 
intensity versus reaction time at each microchannel.  The initial reaction velocity (v0) 
was calculated by measuring the slope of the fluorescence change versus time for the 
first 20 sec (Figure 4.3a).  Then the slope value was divided by the fluorescence density 
from the standard channel with 1.0 mM HMC to yield v0 with the unit of mM/s.  To 
obtain kinetic parameters including Michaelis-Menton constant and maximum velocity 
of the immobilized enzyme, the reciprocal initial velocity 1/v0 was plotted as a function 
of the reciprocal of substrate MUP initial concentration (1/[S], mM-1) as shown in Figure 
4.3b.  The data were fitted to the Lineweaver-Burk equation:177  
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where KM is the Michaelis-Menton constant indicating the affinity that an enzyme has 
for a given substrate, and Vmax is the velocity of the reaction when the active sites of the 
enzyme are saturated with substrate.  The results revealed that Vmax is ~ 0.08 mM/s, and 
KM is ~ 1.47 mM for alkaline phophatase immobilized on 0.08 mol% biotin/POPC 
bilayer surface.   
 
Enzyme Surface Density Estimation  To determine the turnover number 
(kcat, s-1) and catalytic efficiency (kcat/KM, M-1s-1) of the enzymatic reaction, it is 
necessary to estimate the total enzyme concentration ([E]T, mM), since the turnover 
number is obtained from kcat = Vmax/[E]T.177  As alkaline phosphatase was immobilized 
on the membrane, the [E]T can be obtained from enzyme surface density ([E]s, 
nmoles/dm2) with known surface area and volume of the microchannels.  In this study, 
two cases should be discussed about [E]s.  At high biotin concentration in lipid bilayers 
(≥ 1.0 mol%), streptavidin-conjugated alkaline phosphatase can saturate the membrane 
surfaces as described in our previous work.17  In this case, enzyme surface density [E]s 
can be calculated from the footprint size of crystalline streptavidin (~ 33.6 nm2).178  
Since streptavidin-conjugated alkaline phosphatase occupied ~ 4 times greater surface 
area per molecule than streptavidin alone,17 we can get that [E]s at high biotin 
concentration equals ~ 0.124 nmoles/dm2.  With the known microchannel dimensions 
(height ~ 20 µm, width ~150 µm), the total enzyme concentration [E]T was calculated to 
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Table 4.1. The values of Vmax, KM, kcat, and kcat/KM as a function of enzyme surface density. 
Biotin/POPC 
(mol%) 
[B]s 
(nmoles/dm2) 
[E]s 
(nmoles/dm2)
[E]T 
(µM) 
Vmax 
(mM/s)
KM 
(mM) 
kcat 
(s-1) 
kcat/KM 
(µM-1s-1) 
2.0 0.48 0.124 1.405 0.48 2.06 342 0.17 
0.8 0.19 0.095 1.076 0.45 2.10 419 0.20 
0.4 0.095 0.048 0.538 0.24 1.85 447 0.26 
0.2 0.048 0.024 0.265 0.12 1.54 449 0.29 
0.1 0.024 0.012 0.135 0.086 1.49 638 0.43 
0.08 0.019 9.50e-3 0.108 0.080 1.47 741 0.50 
0.04 9.50e-3 4.75e-3 0.0537 0.038 0.99 708 0.72 
0.01 2.37e-3 1.19e-3 0.0134 0.010 0.84 746 0.89 
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be ~ 1.41 × 10-3 mM as shown in Table 4.1.  In the other case, streptavidin-conjugated 
alkaline phosphatase cannot saturate the bilayer-coated microchannel surfaces at low 
biotin concentration in lipid bilayers (less than 1.0 mol%).  The [E]s will then change as 
the decreasing of biotin density in the membrane.  Based on the strong interaction 
between biotin and streptavidin (equilibrium dissociation constant KD, ~ 40 fM),179 three 
assumptions were made in this estimation of enzyme surface density: (1) conjugation of 
phosphatase to streptavidin has no effect on the binding capability of streptavidin, (2) 
every biotin site is available for streptavidin binding, and (3) biotin sites are 100% bound 
to streptavidin at the ratio of 2:1.  Then the value of [E]s equals half of the biotin surface 
density ([B]s), which was calculated following our previously reported procedures.16  
The values for [B]s can be obtained by noting that the area occupied by a POPC 
headgroup is ~ 0.7 nm2/molecule137 and further assuming that the headgroup of biotin-
cap-PE is roughly the same size.  The results of [B]s, [E]s, and [E]T at different biotin 
concentrations were listed in the second and third column of Table 4.1.   
Among the above three assumptions, the third one should be discussed to ensure 
that all biotin sites were bound to streptavidin bivalently under the experimental 
conditions.  When the biotin percentage in lipid bilayers is higher than 0.08%, the biotin 
molecule number in the microchannel walls will be 2 times of that of 0.02 mg/mL (~ 100 
nM) streptavidin in the microchannel.  With the high mobility (~ 4 µm2/s)126 of lipid 
molecules in SLBs as determined by FRAP experiment, two binding sites of streptavidin 
can both bind to biotin.  However, when the biotin density is 0.04 mol% or 0.01 mol% in 
POPC bilayers, some of biotin-streptavidin interactions may be monovalent since the 
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ratio of streptavidin to biotin is higher than 1.0.  In this case, we should calibrate the 
enzyme surface density.  To prove that biotin-streptavidin interaction still follow 
bivalent binding at low biotin surface densities under the experimental conditions, one 
control experiment was conducted by using TIRFM. 
As shown in the inset of Figure 4.4, pure POPC bilayers were formed in the 1st, 
3rd, and 5th channels (from top to bottom) as background control, and 0.04 mol% 
biotin/POPC vesicles were fused through the 2nd, 4th, and 6th channels.  Then Texas Red-
conjugated streptavidin with high concentration (4.0 mg/mL or ~ 66.6 µM) was flowed 
through 5th and 6th channels very quickly, and low concentration solution of Texas Red-
conjugated streptavidin (2.0 × 10-4 mg/mL or ~ 3.33 nM) was flowed through 1st and 2nd 
channels at the rate of 0.05 µL/min.  Since streptavidin concentration in channel 2 is 
much lower than that of biotin and the flow rate is slow, it is easy for the monovalently 
bound streptavidin to encounter free biotin in the bilayer.  So it is reasonable to assume 
that biotin-streptavidin interaction in the 2nd channel is all bivalent binding.  In the 6th 
channel, it is hard for monovalently bound streptavidin to find free biotin in the 
membrane since high concentration streptavidin in bulk solution will quickly occupy all 
biotin binding sites.  In this case, we can assume that the biotin-streptavidin interaction 
includes both bivalent and monovalent binding.  Figure 4.4 demonstrates that the 
fluorescence intensity from channel 6 after subtracting background in channel 5 is ~ 
1.4times of that from the 2nd channel.  This result demonstrates the reasonability of the 
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Figure 4.4.  Intensity line scan of fluorescence from Texas Red-conjugated streptavidin 
bound to the lipid bilayer surfaces across six microchannels.  From top to bottom, 
channel 1, 3, and 5 were coated with pure POPC bilayers, and channel 2, 4, and 6 were 
incubated with 0.04 mol% biotinylated POPC vesicles.  Inset is the TIRF image of the 
six channels when the dye-label streptavidin binding reached equilibrium. 
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 biotin-streptavidin monovalency and bivalency discussion.  In the kinetics study, 0.02 
mg/mL streptavidin-conjugated alkaline phosphatase (~ 100 nM) was used for the 
enzyme immobilization.  For comparison, 100 nM Texas Red-conjugated streptavidin 
was flowed through the 3rd and 4th channels at the same rate (0.05 µL/min) used in the 
enzyme immobilization experiment.  TIRF result in Figure 4.4 shows that fluorescence 
intensity from channel 4 after subtracting the background in channel 3 is very close to 
that from channel 2.  From this result, we could claim that under low biotin surface 
density, biotin-streptavidin interaction still follows bivalent binding and that it is 
reasonable to estimate the enzyme surface density using [B]s.   
 
Kinetics of Immobilized and Free Phosphatase Similar kinetics experiments 
to those shown in Figures 4.2 and 4.3 were performed at eight biotin concentrations 
ranging from 0.01 to 2.0 mol% in POPC bilayers.  The results of Vmax and KM of alkaline 
phosphatase immobilized on each of the biotin/POPC bilayers were extracted using the 
Lineweaver-Burk equation (eqn. 6).  Figure 4.5 shows Lineweaver-Burk plots of the 
reciprocal initial reaction rates (1/v0) versus the reciprocal of MUP concentration (1/[S]) 
for alkaline phosphatases immobilized on various POPC bilayers containing 2.0 mol%, 
0.4 mol%, 0.2 mol%, 0.1 mol%, 0.08 mol%, and 0.04 mol% biotin.  Other kinetic 
information can then be calculated from the known [E]T, Vmax, and KM values.  Table 4.1 
summarizes the values of kinetic paramenters including Michaelis-Menten constant 
(KM), maximum velocity (Vmax), enzyme turnover number (kcat), and catalytic efficiency 
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Figure 4.6.  (a) Fluorescence intensity of HMC produced in the first 20 sec by soluble 
alkaline phosphate in six microchannels.  (b) Lineweaver-Burk plot of the reciprocal 
initial reaction velocity obtained from (a) vs. the reciprocal of MUP substrate 
concentrations for 0.002mg/mL streptavidin-conjugated alkaline phosphatase in solution. 
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(kcat/KM) at various alkaline phosphatase densities ([E]T).  It can be seen that density 
increasing of immobilized alkaline phosphatase on lipid bilayer surfaces can result in an 
increase of Vmax.  The maximum velocity in the microfluidic system can reach ~ 0.5 
mM/s at the high end.  Surprisingly, the change of turnover number follows opposite 
way with the increasing [E]s.  The value of kcat at low end of [E]s is ~ 2 times of that at 
high end.  The enzymatic efficiency increases gradually to 0.89 µM-1s-1 as the enzyme 
surface density decreases.  These phenomena will be discussed later.   
For comparison, the activity of free streptavidin-conjugated alkaline phosphatase 
was also tested in solution for comparison with that of immobilized enzyme.  The 
experimental conditions were identical to those used in kinetic studies of the 
immobilized enzyme, except for the fact that the lipid bilayers in the microchannels were 
absent.  Instead, the streptavidin-conjugated alkaline phosphatase was quickly mixed 
with different concentrations of MUP using VWR Mini Vortexer and injected into each 
channel.  In this case, the enzyme concentration in the bulk solutions was 0.002mg/mL 
(~ 10 nM), which is close to that of the immobilized enzyme at 0.01 mol% biotin/POPC 
membrane.  The MUP substrate concentration ranges from 0.23 mM to 1.80 mM.  
Figure 4.6a shows the conversion of MUP to HMC by plotting the fluorescence intensity 
versus reaction time (first 20 sec) at each microchannel.  Then the bulk solution values 
(KM and Vmax) were measured using the same Lineweaver-Burk analysis as plotted in 
Figure 4.6b.  The results revealed that Vmax = 0.013 ± 0.002 mM/s and KM = 0.88 ± 0.13  
mM.  The turnover number and enzymatic efficiency in bulk solution were ~ 1300 s-1 
and ~ 1.48 µM-1s-1, respectively.  The calculations demonstrate that free alkaline 
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phosphatase in bulk solution shows higher activity and efficiency than the enzyme 
tethered to lipid bilayers.   
 
Discussion 
From the above calculations, the turnover rate of alkaline phosphatase 
immobilized on the 2.0 mol% biotinylated membrane was roughly reduced 4 folds 
relative to the enzyme in solution.  This result is consistent with our previous study,17 in 
which several factors including steric effects and overestimation of enzyme surface 
density, were proposed to explain this phenomenon.  It is not surprising that the high 
surface packing density will lower the accessibility of substrates to enzyme active sites, 
and may favor the conformational change and partial denaturation of the immobilized 
enzyme.  However, few studies were conducted to probe the enzyme activity at low 
surface packing densities.  Herein, the systematic study of effects of enzyme surface 
density on enzymatic activity could provide additional explanation for the apparent 
difference in kcat.   
The kcat values as a function of [E]s from Table 4.1 were plotted in Figure 4.7a.  
As can be seen, the kcat increases slowly as [E]s decreases from 0.12 to 0.024 
nmoles/dm2, and then increases quickly to level out as [E]s decreasing to 0.0012 
nmoles/dm2.  In this case of alkaline phosphatase, it was demonstrated that the turnover 
rate at low enzyme surface densities is higher than that at high densities.  However, the 
work reported by Xu et al.167 and DeLouise et al.168 showed no effect of enzyme surface 
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Figure 4.7.  (a) Turnover rate vs. enzyme density on the lipid bilayer surfaces.  (b) Fitted 
plot of catalytic efficiency as a function of enzyme surface density. 
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Figure 4.8.  Diffusion coefficient of Texas Red-conjugated streptavidin tethered to 
biotinylated POPC bilayers vs. biotin density in the membrane. 
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density on turnover rate, although they agreed that surface immobilization would 
decrease the enzyme activity.  One possibility of the opposite result may be from the fact 
that Xu and Delouise chose different enzymes.  Considering another fact in their work 
that enzymes were immobilized on thiol- or aminosilane-terminated substrates, which 
means the enzyme molecules are not mobile on the surfaces, supported lipid bilayers 
have a unique feature of the fluidity of lipid molecules.  Actually, Strittmatter and 
Rogers180 proposed that a fluid bilayer is necessary to allow protein diffusion for 
efficient enzyme catalytic activity.  They observed that the activity between cytochrome 
and cytochrome b5 reductase was increased 4 folds upon raising the temperature to the 
phase transition temperature of dimyristoyl lecithin liposome.  Thus, enzyme mobility in 
the lipid bilayers could be one reason for the above controversial observation and one 
additional factor for the kcat difference between the immobilized and soluble enzymes.   
To investigate the mobility of enzymes tethered to the lipid membrane, FRAP 
experiments were performed as a function of biotin concentration in supported POPC 
bilayers.  Texas Red-labeled streptavidin, instead of streptavidin-conjugated alkaline 
phosphatase, was chosen for the protein mobility study, since we know that the enzyme 
occupied ~ 4 times greater surface area per molecule than streptavidin alone.17  After the 
formation of dye-labeled streptavidin monolayer on biotinylated POPC bilayers, Ar+/K+ 
laser was applied to make a 17.7 µm full width at half-maximum bleach spot in the 
protein layer.  The recovery of the photobleached spot was monitored by time-lapse 
imaging.  All fluorescence recovery curves were fit to a single exponential to obtain the 
half-time of recovery for the calculation of diffusion coefficient.126  Figure 4.8 shows the 
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effect of biotin density on the diffusion coefficient of streptavidin bound to the 
membrane surface.  As can be seen, bilayer-tethered proteins are not mobile at high 
biotin densities (≥ 4.0 mol%).  The mobility shows an increase as the biotin density 
decreases, and levels out to ~ 2.0 µm2/s when the biotin percentage in POPC is lower 
than 0.8 mol%.  Expanding this result to the case of streptavidin-conjugated alkaline 
phosphatase, it can be estimated that the bilayer-tethered enzyme molecules will be 
immobile at high biotin densities (≥ 1.0 mol%) and reach the maximum mobility when 
the biotin density is lower than 0.2 mol%.  Comparing this result with Figure 4.7a, we 
could claim that the particular property of enzyme mobility can reduce the steric 
crowding effects and accelerate the substrate recognition and accessibility of the enzyme 
active sites, resulting in the increasing of kcat to some extent.   
It should be noted that the kcat in solution is ~ 1.7 times of that at low enzyme 
surface densities, under which the enzyme is highly mobile.  For comparison, the kcat in 
solution is around 4 folds of that at 2.0 mol% biotin/POPC, on which the enzyme is 
immobile.  This fact indicates that besides the steric effects, packing density, etc., 
enzyme fluidity on substrate surfaces should be considered an additional factor for the 
kcat difference between the immobilized and free enzymes.  Considering that the protein 
diffusion coefficient in solution is much higher (10 ~ 100) than that in the fluid bilayer 
surface,181,182 it is easy to understand why the free alkaline phosphatase in solution still 
holds higher turnover rate than the fluid one in the lipid membrane.   
Effects of enzyme surface density on KM and kcat/KM should also be discussed.  
The KM values were gradually reduced with decreasing enzyme surface density.  Since 
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KM is an indicator of the affinity that an enzyme has for a given substrate,177 the result 
means the recognition process of the enzyme and substrate was accelerated at decreased 
enzyme densities.  This is consistent with the observation reported by Xu et al.167  The 
kcat/KM, a measure of an enzyme’s catalytic efficiency, was plotted in Figure 4.7b versus 
enzyme surface density.  The catalytic efficiency decreases sharply as a function of [E]s 
at low densities, but begins to level out at higher densities.  This curve could be fit by a 
single-exponential decay function: y = y0 + Ae-kx, where y is the quantity kcat/KM, y0 is 
the lowest catalytic efficiency, A is a proportionality factor, x is enzyme surface density, 
and k is the apparent constant indicating the effect of [E]s on enzymatic efficiency.  The 
abstracted parameters are y0 = 0.20 µM-1s-1, A = 0.78 µM-1s-1, and k = 98.0 nM-1dm-1.  It 
can be inferred that at infinite low [E]s, the catalytic efficiency of the immobilized 
enzyme can reach 0.98 µM-1s-1, which will be the highest enzymatic efficiency that the 
lipid bilayer-tethered phosphatase can obtain.  This result demonstrates that the highly 
fluid enzymes on the membrane can get ~ 5 times improvement of the catalytic 
efficiency relative to the immobile enzymes.   
 
Conclusion 
In the experiments presented in this chapter, enzyme kinetics of alkaline 
phosphatase tethered on phospholipid bilayers was investigated using microfluidic 
devices in conjunction with epifluorescence microscopy.  Systematic studies on the 
enzymatic activity of phosphatase were undertaken as a function of enzyme surface 
density.  The turnover rate and enzymatic efficiency for the immobilized phosphatase 
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were highly improved at low surface densities, although the enzyme in solution holds the 
highest activity and efficiency.  This observation was ascribed to the high substrate 
accessibility and affinity to the enzyme active sites, as well as the high fluidity of lipid 
bilayer-bound enzyme molecules at low surface densities. 
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CHAPTER V 
SUB-100 NM PATTERNING OF SUPPORTED BILAYERS  
BY NANOSHAVING LITHOGRAPHY 
 
Introduction 
Controlling the chemical composition of supported phospholipid bilayers (SLBs) 
on the micron and submicron scale has been a widely pursued goal in bioanalytical 
chemistry.  For example, Jackson and Groves85 applied scanning probe lithography to 
completely remove lipid membranes in pre-patterned 1 × 1 µm chromium arrays and 
then backfilled these regions with new lipid components.  Orth and coworkers 
demonstrated ~ 1 µm scale SLB patterning using an elegant polymer lift-off method.76  
Lenhert et al.82 developed a dip-pen nanolithography method for patterning 
bilayer/multi-bilayer structures down to the 100 nm scale.   
These patterned membranes can be employed to address fundamental biophysical 
questions about cell membrane behavior.26,37,91  For instance, Mossman and colleagues37 
showed that the radial location of T-cell receptors can be finely tuned in immunological 
synapses by using micropatterned SLBs.  Wu et al.91 demonstrated that micropatterned 
bilayers are useful for the visualization of membrane compartmentalization during 
receptor-mediated signaling.  The fine patterning of lipid membranes may also serve as 
the basis for a variety of biosensor technologies.13  One example is the formation of 
*Reproduced with permission from “Sub-100 nm Patterning of Supported Bilayers by Nanoshaving
Lithography” by Shi, J. J.; Chen, J. X.; Cremer, P. S.  J. Am. Chem. Soc. 2008, 130, 2718-2719.
Copyright 2008 American Chemical Society. 
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submicron-sized SLBs inside Au nanoholes (~ 110 nm), which have been employed for 
label-free biorecognition in conjunction with localized surface plasmon resonance.87,88   
Despite these successes, it is generally agreed that supported membrane 
patterning below the 100 nm scale would add an important new dimension to 
biophysical and bioanalytical studies.  There should, however, be an ultimate size limit 
to free-standing SLB formation because these supramolecular architectures pay the cost 
of an edge energy in order to fuse to solid supports.183,184  Chapter V used atomic force 
microscopy (AFM) based nanoshaving to control the formation of SLBs down to the 
sub-100 nm level.  Nanoshaving employs an AFM tip to selectively remove a pre-
existing thin film from a substrate.159,185-189  The shaved region can be subsequently 
backfilled with new materials such as an SLB.  The results in this chapter revealed that 
lines of phosphatidylcholine bilayers possessing widths as thin as 55 nm can be 
patterned on borosilicate supports, but not lines with 36 nm widths. 
 
Experimental 
Materials Bovine serum albumin (BSA) and Texas Red-conjugated BSA 
were purchased from Molecular Probes, Inc. (Eugene, OR).  1-Palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC), 1,2-dihexanoyl-sn-glycero-3-phosphocholine 
(DHPC), and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-
benzoxadiazol-4-yl) (Ammonium Salt) (NBD-PE) were purchased from Avanti Polar 
Lipids (Alabaster, AL).  Phosphate buffered saline (PBS) solutions were used in all 
experiments.  These solutions contained 20 mM sodium phosphate, 150 mM NaCl, and 
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0.2 mM sodium azide.  The pH of the solution was set to 7.4 by the dropwise addition of 
2.0 M NaOH.  Purified water for these experiments came from a NANOpure Ultrapure 
Water System (≥18.2 MΩ·cm, Barnstead, Dubuque, IA).  Borosilicate glass coverslips 
(VWR Scientific, No. 1, 22 × 22mm) were used as substrates for protein monolayer and 
lipid bilayer formation.  It should be noted that the substrates were cleaned in a boiling 
1:3 solution of ICN ×7 detergent and purified water.  After cleaning, the substrates were 
rinsed with copious amounts of purified water, dried with nitrogen, and annealed in a 
kiln at 480 °C for 5 hours.   
 
Vesicle Preparation Small unilamellar vesicles (SUVs) were prepared by 
vesicle extrusion.47,48  Lipids dissolved in chloroform were dried under a stream of 
nitrogen followed by overnight vacuum desiccation.  Next, the lipids were rehydrated in 
PBS solution.  After five freeze-thaw cycles, the vesicles were extruded more than seven 
times through a polycarbonate filter (Whatman) containing 50 nm pores.  These vesicles 
had a size distribution centered around 70 nm as determined by dynamic light scattering 
(Brookhaven Instruments 90Plus Particle Size Analyzer).  These vesicles were employed 
to obtain all the data obtained in the main text.  POPC vesicles containing 2.0 mol% 
NBD-PE were also extruded more than seven times through a polycarbonate filter 
(Whatman) containing 30 nm pores.  The center of the size distribution for these vesicles 
was approximately 34 nm.   
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Epifluorescence Microscopy  Epifluorescence images of protein patterns 
and SLB lines were obtained using a Nikon E800 fluorescence microscope equipped 
with a MicroMAX 1024B CCD camera (Roper Scientific).  Removal of BSA was 
confirmed by fluorescently tagging protein molecules at a low degree of labeling (1 
molecule in 20) with Texas Red and visualizing the system under the epifluorescence 
microscope.  To check the quality and fluidity of the SLB lines, one-dimensional 
fluorescence recovery after photobleaching (FRAP)190 studies were conducted using an 
inverted epifluorescence Nikon Eclipse TE2000-U microscope equipped with a Nikon 
Plan Fluor 40× oil immersion objective (NA 1.30).  Laser radiation (488 nm, 200 mW) 
from a mixed gas Ar+/K+ laser (Stabilite 2018, Spectra Physics) was used to bleach the 
lipid bilayer samples.  Bleaching times were less than 1 second and FRAP images were 
captured with the MicroMAX CCD camera.   
 
Atomic Force Microscopy A Nanoscope IIIa Multimode SPM (Digital 
Instruments, Santa Barbara, CA) equipped with a J-type scanner was used for 
nanoshaving lithography and AFM imaging of BSA monolayers.  An etched silicon tip 
(NSC15/NoAl; spring constant: ~ 40 N/m; MikroMasch, Wilsonville, OR) was used as 
the AFM probe.  All images were obtained in tapping mode at a scan rate of 0.5 Hz.  The 
only treatment applied to the images was flattening.   
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Figure 5.1.  Schematic representation of AFM-based nanoshaving lithography for 
nanoscale SLB formation.  The red and gray ellipsoids represent adsorbed BSA 
molecules.  The gray ones are being removed by the AFM tip.  A subsequently deposited 
lipid bilayer is shown in green. 
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Results and Discussion 
A three-step process was conducted to create lines of SLBs as shown 
schematically in Figure 5.1.  First, a bovine serum albumin (BSA) monolayer was 
formed on a planar borosilicate substrate by incubation with a phosphate buffered saline 
(PBS) solution containing 10 mg/mL BSA.155  Excess protein molecules were washed 
away with purified water and the BSA monolayer was subsequently dried under 
streaming nitrogen.  In a second step, immobilized protein molecules were selectively 
removed with an ultrasharp AFM tip in air in contact mode to create vacant lines with 
varying widths.  The force applied to the tip was ~ 300 nN, which was sufficient to 
remove the protein without damaging the underlying surface.  It should be noted that the 
Si tip was moved laterally in 2 nm steps in a process controlled by patterning software.  
The nanoshaving speed was 40 µm/s.  The width of the patterned lines was directly 
measured by AFM.  For convenience, 1 in 20 proteins was fluorescently tagged so that 
vacant regions could be observed by epifluorescence microscopy.   
Backfilling was performed with a 0.5 mg/mL vesicle solution composed of 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) with 2.0 mol% of a dye-
labeled lipid (NBD-PE).191  Small unilamellar lipid vesicles were incubated over the 
nanopatterned BSA substrate for 10 min.  After rinsing with PBS solution, fluorescence 
microscopy clearly showed uniform fluorescence from 55 nm wide lines down to the 
diffraction limit (Figure 5.2a).  This is consistent with the presence of lipid material 
within the shaved regions.  The mobility of the bilayer in this narrow region was  
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Figure 5.2.  FRAP images of 2.0 mol% NBD-PE/POPC bilayer lines as a function of 
time that are ~ 55 nm in width.  The bleached bilayer spot is shown (a) before bleaching, 
(b) immediately after bleaching, and (c) 120 sec later.  The red circle denotes the 
location of the bleach spot.  Only the bottom line was bleached and the upper one was 
used as a reference.  The scale bar is 3 µm. 
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confirmed by one-dimensional fluorescence recovery after photobleaching 
(FRAP)190measurements.  Figure 5.2b & 5.2c show the bleached spot immediately after 
it was made and 120 sec later, respectively.   
To calculate the value of the diffusion constant, a one dimensional diffusion 
equation190 was employed: 
C0,t = C0,0 × Ro(Ro2 + 8Dt)-1/2    (7) 
where C0,0 is the concentration of the bleached dye at the center point of the bleaching 
profile (Figure 5.3) at 0 sec, C0,t is the concentration of the bleached dye at the center 
point of the bleaching profile as a function of time, Ro is the half-width (1/e2) of the 
bleach spot, and D is the diffusion constant.  In the case of Figure 5.3, the half-width of 
the bleach spot is ~ 7.2 µm as calculated by fitting the initial bleaching profile (t = 0 sec) 
to a Gaussian profile.   
From eqn. 7, a plot of (C0,0/C0,t)2 vs. time t should yield a straight line with a 
slope of 8D/Ro2.  Figure 5.4 shows the linear relationship with a slope of 0.35 sec-1.  
Hence, D = 2.3 × 10–8 cm2/s.  The average of 3 trials yielded a diffusion constant of 2.5 
± 1.4 × 10–8 cm2/s.  The mobile fraction was calculated by comparing the fluorescence 
intensity of the bilayer region before photobleaching and after recovery.  The bottom 
line in Figure 5.3 was used a reference marker for the calibration of excitation light 
intensity and dye bleaching by continued imaging.  Note that the bleached area must also 
be considered for the mobile fraction calculation, because the bleach spot occupied ~  
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Figure 5.3.  Time-lapse epifluorescence images of 2.0 mol% NBD-PE/POPC bilayer 
lines.  The top line was bleached at the center, and the bottom one was used as a 
reference marker. The scale bar is 6 µm.   
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Figure 5.4.  (C0,0/C0,t)2 vs. time for the calculation of the diffusion constant. 
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16% of the top line in Figure 5.3.  Taking this into account yields a mobile fraction of ~ 
0.97.   
Next, a series of parallel lines ranging from 15 to 600 nm were formed under an 
identical set of nanoshaving conditions.  After nanoshaving, the Texas Red-labeled BSA 
monolayer was imaged by epifluorescence microscopy (Figure 5.5a).  Close-up AFM 
images for the identical protein line widths are provided in Figure 5.6.  At this point, 
POPC vesicles containing 2.0 mol% NBD-PE were introduced over the sample.  
Epifluorescence images of the nascently formed lipid bilayers from this process are 
shown in Figure 5.5b.  The smallest bilayer lines created by this method were 55 nm.  
On the other hand, the lipid material completely and consistently washed away from the 
surface when the line width was 36 nm or below.  This finding was not changed by 
modulating the size of the vesicles.   
Although sub-100 nm bilayer lines could be created, there is a clear size limit for 
POPC/glass bilayers.  All free-standing SLB patches formed on solid supports (e.g. 
borosilicate glass) have an edge energy associated with them.  Indeed, the bilayer is, 
presumably, highly curved along its perimeter to avoid exposing the hydrophobic lipid 
tails directly to water.183,192  The concept of edge energy per unit length (γ, J/m)183 
describes the curvature cost over a given distance.  The reason micron scale lipid 
bilayers readily fuse to planar supports is because the adhesion energy more than 
compensates for such line tension.184  By contrast, the edge energy can be greater than 
the adhesion energy for nanoscale bilayers.   
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Figure 5.5.  Epifluorescence images of (a) a nanoshaved BSA monolayer and (b) SLB 
lines.  The top line, which is ~ 200 nm in width, was used as a reference marker.  The 
widths of shaved lines in (a) from 1 to 8 are ~ 600 nm, ~ 300 nm, ~ 142 nm, ~ 103 nm, ~ 
78 nm, ~ 55 nm, ~ 36 nm, and ~ 15 nm, respectively, as measured by AFM.  The length 
of each line is 40 µm.  The scale bar is 3 µm.  Note, the vacant lines in (a) become 
increasingly difficult to observe by epifluorescence microscopy as the line width 
narrows.  Green fluorescence emanating from these regions, however, should be trivial 
to observe even for the thinnest lines under the conditions of this experiment, if a bilayer 
is indeed present. 
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Figure 5.6.  AFM images of a series of nanoshaved lines in a BSA monolayer.  The 
width of the lines are:  (a) ~ 15 nm, (b) ~ 36 nm; (c) ~ 55 nm; (d) ~ 103 nm; and (e) ~ 
300 nm.  The image size of (a), (b), (c), and (d) is 1 µm × 1 µm.  The image size for (e) 
is 2 µm × 2 µm.   
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In the present case, bilayers are w µm wide and l µm long.  Therefore, the edge 
energy, Ee, and surface adhesion energy, Es, should be: 
Ee = γ × 2(w + l)     (8) 
Es = W × wl      (9) 
where W is the surface adhesion energy per unit area.  Neglecting any interactions 
between the bilayer edge and the surrounding BSA molecules, the surface adhesion 
energy (eqn. 9) must be greater than or equal to the edge energy (eqn. 8) in order for a 
stable SLB to form: 
W × wl ≥ γ × 2(w + l)     (10) 
since the length of the bilayer lines (e.g. 40 µm) is two to three orders of magnitude 
larger than their widths, eqn. 10 can be reduced and rearranged to: 
w ≥ 2γ / W      (11) 
where the equality describes the minimum size for an SLB.  The adhesion energy per 
unit area (W) of phosphocholine bilayers on glass substrates has been estimated to be ~ 
2.0 × 10-4 J/m2 in several reports.88,192-194  Moreover, the typical edge energy per unit 
length (γ) of a phosphocholine bilayer is known to be ~ 1 × 10-11 J/m.195-199  This leads to 
an estimated lower width limit of ~ 100 nm.  Such a value is in reasonably good 
agreement with our finding of 55 nm.  However, our number implies that W may be 
somewhat larger and/or that γ might be somewhat smaller.  A slightly lower value of γ in 
the present case, for example, might stem from a slightly favorable interaction between 
the bilayer edge and neighboring BSA molecules.   
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The size limitations found in this chapter are almost certainly specific to the lipid 
composition of the membrane.  Modulating the composition should lead to changes in γ.  
For example, supported bilayers comprised of a mixture of long-chain phospholipids 
with a small concentration of 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) 
would be expected to have a lower edge energy and thus allow narrower line widths to 
be achieved.  In fact, such compositions are often used to make lipid bicelles in bulk 
solution.200  These pancake-like bilayer structures probably reduce edge energy by 
having a high concentration of DHPC along the edge.  In fact, control experiments with 
POPC bilayers containing 6.0 mol% DHPC showed that ~ 36 nm wide lines could be 
made, but not ~ 15 nm. 
 
Conclusion 
Sub-100 nm wide supported phospholipid bilayers (SLBs) were patterned on a 
BSA patterned planar borosilicate substrate by AFM-based nanoshaving lithography.  
Bilayer lines were formed within the BSA vacant strips by vesicle fusion method.  It was 
found that stable bilayers formed by this method had a lower size limit of ~ 55 nm in 
width.  This size limit stems from a balance between a favorable bilayer adhesion energy 
and an unfavorable bilayer edge energy.  The size limitations found in this chapter can 
be modulated by changing the lipid composition of the membranes.  SLB arrays formed 
by this technique are expected to be very applicable for studying cell adhesion and 
growth, cell signaling, and the creation of biosensors. 
 106
CHAPTER VI 
MEMBRANE-ASSOCIATED SPECIES SEPARATION BY POLYMER-
CUSHIONED LIPID BILAYER ELECTROPHORESIS 
 
Introduction 
Since the first demonstration in 1977 that electric fields can reorganize the 
membrane-bound protein of Con A in cell membranes,201 electrophoresis in solid-
supported lipid bilayers has attracted considerable attentions.  The technique has been 
applied in accumulation, reorganization, and separation of membrane components 
including charged lipids202,203, tethered vesicles204, and GPI-linked proteins205.  More 
recently, two modified electrophoresis methods have been developed for the separation 
of lipid-associated fluorophores in SLBs.  Daniel et al.19 created a planar bilayer 
separation medium composed of phosphatidylcholine and cholesterol mixtures, which 
can limit the band broadening during electrophoresis.  A complex mixture of lipids, 
tagged with three fluorescent labels, was isolated in this system.  To overcome the 
productive limitation of planar bilayer system, Suzuki et al.39 described a large-scale 
separation method by using a packed bed of bilayer-coated particles as an 
electrophoretic medium.   
Electrophoresis in solid-supported lipid bilayers is now accepted as an ideal 
strategy to separate biomembrane species including lipids and transmembrane proteins, 
since the process does not require harsh conditions such as detergent extraction, and can 
maintain the structure and function of membrane components, compared to conventional 
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methods.  However, this method suffers from one fundamental drawback.26  When 
transmembrane proteins, especially those presenting large peripheral domains, are 
incorporated in solid-supported lipid bilayers, the bilayer-substrate distance (~ 1 nm)25 
does not provide sufficient space to avoid the direct contact between the proteins and the 
solid surface, thus causing the immobilization and/or denaturation of the proteins.   
Polymer-supported lipid bilayer system was thus proposed to separate the lipid 
membrane from the solid substrate by adding one ultrathin hydrophilic polymer layer 
between them.  There are two main classes of polymers suitable for biomembrane 
supports.  When lipid bilayers are created on polymer films, such as cellulose53,54 and 
polyelectrolytes57-61, which are deposited on solid substrates by physical absorption 
techniques, this system is called polymer-cushioned lipid bilayer.  The polymer cushions 
behave like a cytoskeleton.  The other strategy utilizes lipopolymer tethers to support 
bilayer formation.  These polymers include one terminal group that binds to the 
substrate, another terminal group that inserts into the lipid bilayer, and one hydrophilic 
linker (e.g. polyethylene glycol, PEG) that defines the space between the substrate and 
the bilayer.62-66  It is proven that membrane proteins are mobile and functional in such 
polymer-supported bilayer systems.26 
This chapter investigated the separation of membrane-associated species by 
polymer-cushioned lipid bilayer electrophoresis.  Bilayer separation medium was 
prepared on different polymer cushions including cellulose, polylysine, and poly-(N-
isopropylacrylamide) (PNIPAM).  The bilayer containing lipid-tagged fluorophores was 
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Figure 6.1.  Schematic representation of the general steps for patterning and separation 
of membrane-associated species in polymer-cushioned lipid bilayers.   
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deposited adjacent to the separation medium by a three-step process (Figure 6.1).  By 
applying potential laterally across the lipid bilayer, the Texas Red isomer mixtures were 
separated in the polymer-supported bilayer medium.  This method was extended to the 
patterning of Escherichia Coli (E. Coli) membrane in the bilayer separation medium.  
The separation of membrane-associated proteins was discussed.   
 
Experimental 
Materials 1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine (POPC), 1,2-
dilauroyl-sn-glycero-3-phosphocholine (DLPC), 1,2-Dipalmitoyl-sn-Glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (Ammonium Salt) (NBD-
PE) and cholesterol were purchased from Avanti Polar Lipids (Alabaster, AL).  Texas 
Red 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt 
(TR-DHPE) was obtained from Molecular Probes (Eugene, OR).  Polymers including 
cellulose, polylysine, and poly-(N-isopropylacrylamide) were purchased from Sigma-
Aldrich (St. Louis, MO).  E. Coli vesicles were provided by Dr. Musser at Texas A&M 
Health Science Center. 
Phosphate buffer saline (PBS) was made with 5 mM Na2HPO4, 5 mM NaH2PO4 
and 150 mM NaCl.  The pH was adjusted to 7.4 using sodium hydroxide.  PBS solution 
was used in the preparation of vesicles.  The purified water used in the preparation of all 
solutions was obtained from a NANOpure Ultra Water System (Barnstead, Dubuque, 
IA) with a minimum resistivity of 18 MΩ·cm.  Quartz coverslips (1×1 inch, 0.2 mm 
thick, Electron Microscopy Sciences, Hatfield, PA) were used as substrates for bilayer 
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formation, and boiled in 7X solution (MP Biomedicals, Aurora, OH) that was diluted 
four fold by volume with purified water.  Platinum electrodes were made from platinum 
wire with a diameter of 0.25 mm from Alfa Aesar (Ward Hill, MA).   
 
Thin polymer film preparation Cellulose film was prepared by Langmuir-
Blodgett deposition of synthetic trimethylsilyl cellulose (TMSC) onto hydrophobic 
substrates and regenerated with HCl vapor.206  TMSC was synthesized as following.  
Cellulose powder was first dissolved in the solution of 5-8% (w/w) lithium chloride / 
dimethylacetamide.  The solution was then heated to 80 oC and hexamethyldisilazane 
was added in a steady flow in a nitrogen atmosphere.  The reaction was kept overnight 
(~ 10 h).  The product was cooled and some methanol was added to enhance the 
crystallization of TMSC, which was left to proceed overnight.  Next, the methanol was 
added slowly till TMSC precipitates from the solution at 50°C.  The crystallized TMSC 
was filtered and dissolved into tetrahydrofuran and recrystallized in methanol. After 
filtration, the recrystallized TMSC was washed several times with methanol and dried in 
a vacuum desiccator.  NMR spectrum demonstrated that the silylated cellulose has a 
degree of substitution of ~ 2.4. 
For the preparation of the TMSC film, a solution of 5 mg TMSC in 10 ml n-
hexane was spread onto a water surface in a KSV5000 trough (KSV Instruments, 
Monroe, CT) at room temperature.  The monolayer was compressed up to 17 mN/m and 
the deposition onto quartz slides surfaces was performed with a dipping speed of 1 
cm/min.  The quartz slides had been hydrophobized by incubation with 2.5mM OTS in 
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toluene for 1 hour.  After six dip-coating cycles, the TMSC film was exposed to HCl 
vapor for the regeneration of cellulose film. 
 Other polymer films were prepared by immersing the cleaned solid substrates in 
1.0 mg/ml aqueous solution of polylysine or PNIPAM for 1 hour at room temperature.  
The bulk polymers in the solution were washed away with copious amounts of water. 
 
Separation medium preparation The separation bilayer was formed on 
polymer cushions by vesicle fusion.9  The vesicle solution was prepared by vesicle 
extrusion.47,48  Lipids dissolved in chloroform were dried under a stream of nitrogen 
followed by overnight vacuum desiccation.  Next, the lipids were rehydrated in PBS 
solution.  After five freeze-thaw cycles, the vesicles were extruded more than seven 
times through a polycarbonate filter (Whatman, Fisher Scientific) containing 50 nm 
pores.  These vesicles had a size distribution centered around 70 nm as determined by 
dynamic light scattering (Brookhaven Instruments 90Plus Particle Size Analyzer).  The 
vesicle solutions were incubated on polymer films for 10 min.  The vesicles in bulk were 
then washed away with copious amounts of purified water. 
To check the quality and fluidity of polymer-cushioned bilayers, FRAP studies 
were conducted using an inverted epifluorescence Nikon Eclipse TE2000-U microscope 
with a 10× objective.  Laser radiation from a 2.5 W mixed gas Ar+/K+ laser (Stabilite 
2018, Spectra Physics) was used to bleach the lipid bilayer samples.  Fluorescence 
recovery after photobleaching (FRAP)125 images were obtained with a MicroMax 1024b 
CCD camera (Princeton Instruments). 
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Electrophoresis Electrophresis in the polymer-cushioned lipid bilayer was 
conducted with a standard regulated power supply (Lambda Electronics Corp., Long 
Island, NY) while monitoring the current through the system with a digital multimeter 
(Keithly).  A 100 V potential was applied laterally across the bilayer by using platinum 
wire electrodes.  Purified water was used to minimize Joule heating.  Joule heating was 
negligible since we maintained currents of only a few microamps or less during all 
experiments.  Epifluorescence image were captured by a Nikon E800 fluorescence 
microscope with a Roper Scientific Micromax CCD camera.  Time-lapse images were 
collected through a 4× Nikon objective to monitor the movement of the fluorescent 
bands and subsequent separations. 
 
Results and Discussion 
In a first set of experiments, the formation of lipid bilayers on polymer cushions 
was tested.  TR-DHPE/POPC vesicles were used to demonstrate the vesicle fusion on 
polymer cushions.  The inset fluorescence images in Figure 6.2 show that the TR-
DHPE/POPC bilayer is uniform on the cellulose film down to the diffraction limit.  The 
mobility of lipid molecules in the polymer-cushioned bilayer were confirmed by the 
FRAP technique.  The diffusion constant calculated from the FRAP recovery curve was 
~ 2.4 µm2/s with a mobile fraction of ~ 95%.  Similar results were also obtained on 
polylysine and PNIPAM cushions.   
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Figure 6.2.  FRAP recovery curve for 0.1 mol% TR-DHPE/POPC bilayer on a cellulose 
cushion.  Inset is the fluorescence images right after photobleaching and after recovery. 
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Next, it is necessary to test that membrane-associated species can be patterned in 
polymer-cushioned bilayer medium and separated.  In this experiment, POPC bilayers 
containing TR-DHPE isomers were chosen for demonstration.  At the beginning, DLPC 
bilayers with 25 mol% cholesterol and 2 mol% NBD-PE were formed on the PNIPAM 
thin film.  Bilayers and polymers were then selectively removed by using either a sharp 
tip or deep UV radiation (~ 2.8 W, UVP Inc., Upland, CA).  Deep UV with ~ 190 nm 
wavelength can completely remove the bilayer and polymer.54,79,95  The surface was then 
washed with copious amounts of purified water.  Next PNIPAM solution was again 
incubated with the patterned surface for 1 hour to refill the polymer gap.  After washing 
away the polymers in bulk, vesicles containing 2.0 mol% TR-DHPE isomers were 
introduced into the aqueous phase above the surface for 10 min.  Figure 6.3 illustrates 
that two thin lines of DLPC/cholesterol/NBD bilayer were removed by a sharp tip and 
the lines were refilled with POPC/TR-DHPE bilayers.   
To demonstrate that the TX-DHPE isomers can be separated in the polymer-
cushioned DLPC/cholesterol medium, an electric field was applied parallel to the bilayer 
plane.  Epifluorescence images in Figure 6.4 show the original band was moved across 
the polymer-cushioned separation medium with compact format and resolved into two 
distinct band features after 30 min.  The area ratio of the two bands is ~ 70:30, which is 
consistent with the result published by Daniel et al.19  It is also proven that the separated 
bands represent two TX-DHPE isomers.19  This result testify that electrophoresis in 
polymer-cushioned lipid bilayers is capable of separating membrane-associated species.   
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Figure 6.3.  Epifluoresence image of (a) polymer-cushioned DLPC/cholesterol/NBD-PE 
bilayer after 10 min deep UV irradiation, and (b) POPC/TX-DHPE bilayer after polymer 
film regeneration and vesicle fusion. 
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Figure 6.4. Separation of TX-DHPE isomers in a PNIPAM-cushioned DLPC/cholesterol 
medium.  The top and bottom fluorescence signal comes from TX-DHPE before and 
after 30 min electrophoresis. 
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The possibility of extending the polymer-cushioned bilayer electrophoresis 
method to the purification and separation of membrane proteins is disscused in the final 
sets of experiments.  For this purpose, we used E. Coli vesicles (~ 300 nm in diameter) 
containing overexpressed Tat (twin-arginine translocation) machinery as an exmaple.  
The E. Coli vesicle solution was incubated with the polymer-coated glass substrate for 1 
hour.  Then extra vesicles were washed away with copious amounts of water.  To 
visualize the membrane on polymer cushions, Alex594 solution was added into the bulk 
solution.  After one hour labeling reaction, the dye molecules in the solution were 
flushed away.  It was assumed that the dye would link to the membrane proteins and 
membrane species with free amine groups, since E.Coli membrane contains high 
concentration phosphatidylethanolamines.207 
The inset images in Figure 6.5 illustrate that Alexa594 molecules were labeled to 
the E. Coli membrane surface.  To demonstrate E. coli vesicles can rupture to form 
polymer-cushioned biomembrane and the membrane is mobile, FRAP experiments were 
carried out for the mobility measurement of dye molecules.  Results demonstrate that the 
fluorescence can get recovered after photobleaching, although it takes much more time 
than that in Figure 6.2.  The FRAP recovery curve was fit to a double exponential 
equation, since Alexa594 was labeled to more than one species in the membrane.  The 
diffusion constants calculated from the curve fitting was ~ 0.05 µm2/s and ~ 3.8 µm2/s.  
The mobile fraction is ~ 74%.  We speculate that the slow mobility comes from the dye-
labeled proteins, and the fast from dye-labeled lipid molecules.   
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Figure 6.5.  FRAP recovery curve for Alexa594-labeled E. Coli membrane on a polymer 
cushion.  Inset is the fluorescence images immediately after photobleaching and 80min 
later. 
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The slow mobility of proteins may be ascribed to the high content of proteins 
associated in the membrane, which can even prevent the fusion of vesicles.68  To solve 
the slow mobility problem, high protein concentration must be diluted.  Several 
techniques have been proposed for this purpose by fusion of artificial SUVs with E. Coli 
vesicles to form lipid-enriched proteoliposomes.68,208,209  The technique adopted in this 
chapter will utilize extrusion or sonication method to prepare small proteoliposomes, 
which are proven to be efficient for supported biomembrane formation.  Experiments, 
including mixing E. Coli vesicles and artifical vesicles in various proportions for vesicle 
fusion and testing which one gives the best mobility, is in progress.  With patterning of 
the E. Coli biomembrane containing highly mobile proteins adjacent to polymer-
coushioned bilayer separation medium (Figure 6.1), it is expected the proteins could be 
moved and separated by electrophoresis. 
 
Conclusion 
The results presented in this chapter demonstrate that lipid bilayers can be 
deposited on different polymer cushions including cellulose, PNIPAM, and polylysine.  
Such polymer-supported lipid bilayers are uniform and mobile.  Different biomembranes 
can be patterned together on polymer cushions by deep UV lithography.  Electrophoresis 
isolation of lipid-tagged fluorophore isomers was achieved in polymer-cushioned bilayer 
separation medium containing the mixture of phospholipid and cholestrol.  The result is 
consistent with the published studies using solid-supported lipid bilayers by Daniel et 
al.19  This method is also extended to the separation of proteins in E. Coli membrane, 
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since polymer cushiones are able to keep the membrane proteins mobile and 
functional.26  The preliminary data demonstrate that E. Coli vesicles can rupture on 
polymer cushiones and form mobile bilayers.  Although the protein mobility in the E. 
Coli membrane is slow, proteoliposome formation could be one way to solve this 
problem by diluting the high protein concentration with artificial vesicles.  Further 
studies of proteoliposome preparation and electrophoresis separation of membrane 
proteins are underway. 
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CHAPTER VII 
SUMMARY AND OUTLOOK 
 
During my time at Texas A&M University, I have foucsed my research on the 
development of novel lithographic techniques for micro/nano-patterning supported lipid 
bilayers and have applied patterned biomembrane arrays to address some biophysical 
and bioanalytical questions.  Here, I will summarize the research work I achieved and 
am currently doing.  I will also discuss some potential future directions of SLB 
patterning. 
My starting project was the study of multivalent interactions between CTB and 
GM1 by using lipid bilayer-coated microfluidic platforms.  Ligand density and ligand 
presentation effects on protein binding revealed that the CTB-GM1 binding weakened 
with increasing GM1 density.  AFM demonstrated the clustering of GM1 on the 
supported lipid bilayers, which in turn inhibits the binding of CTB.  Although such 
bilayer-coated microfluidic devices showed high throughput and low consumption 
properties, these assays could still be improved considerably by measuring multiple 
binding constants for various membrane chemistries simultaneously.  Deep UV 
lithography was utilized for arraying a variety of different lipid bilayers in individual 
microfluidic channels coated with one protein layer.  Such two dimensional assays were 
successfully applied to probe multivalent binding as a function of four ligand densities in 
one-shot experiments.  Bilayer-coated microfluidics is also useful for enzyme kinetics.  
Streptavidin conjugated enzymes were immobilized at the biotin sites in SLBs, and 
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enzyme kinetics was monitored by fluorescence signal change from dephosphorylation 
reactions.  Higher turnover rate and catalytic efficiency was observed at low enzyme 
surface density, which was ascribed to the high mobility of enzyme molecules on the 
membrane surface.   
Next, sub-100 nm patterning of supported lipid bilayers was achieved by atomic 
force microscopy (AFM) based nanoshaving lithography.  By considering the favorable 
bilayer adhesion energy and the unfavorable bilayer edge energy, it is believed that the 
phospholipid bilayer size limit of ~ 55 nm in width is inherent.  The size limitations are 
also specific to the lipid composition of the membrane.  Finally, polymer-cushioned lipid 
bilayers were proposed for electrophoretic separation of membrane-associated sepcies.  
Lipid-tagged fluorophore isomers were separated by this strategy.  E. Coli ghost 
membrane formation on polymer cushions was demonstrated and the separation of 
membrane-associated proteins was discussed. 
Supported lipid bilayer arrays will attract more and more applications in 
biophysical and bioanalytical studies, especially with the development of new patterning 
techniques.  Lipid bilayer patterning in a single microchip can be utilized to study cell-
matrix and cell-biomaterial interactions.  For example, if SLB patches containing 
different ligands (such as RGD peptides)210 are arrayed within individual microchannels, 
we can simultaneously observe the growth of cells on different patches, which will be 
useful for ligand screening.  The adhesion of different cells on bilayer arrays can be 
employed in a high-throughput assay for studying interactions between cells and 
biomaterials (e.g. aptamer-conjugated micro/nano-particles).211  Such bilayer-arrayed 
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microfluidic platforms are also suitable for the study of blood clotting as a function of 
fluid flow and bilayer patch shape.212  Besides, SLB arrays containing functional groups 
(e.g. carboxyl group) could play a role in controlling the growth of bio-inspired materials 
such as calcium carbonate.213,214  The unique properties of SLBs will make them better 
templates mimicking the biomineralization in nature.  Furthermore, the coupling of a 
temperature or concentration gradient96 with such bilayer-arrayed platforms will make 
the tool much more powerful. 
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